Population Council

Knowledge Commons

2013

Mainstreaming emergency contraception in developing countries:
A toolkit for policymakers and service providers
Wilson Liambila
Population Council

Saumya RamaRao
Population Council

Joyce Wanderi Maina
Mary W. Gathitu

Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh
Part of the Demography, Population, and Ecology Commons, Family, Life Course, and Society
Commons, International Public Health Commons, and the Medicine and Health Commons

How does access to this work benefit you? Let us know!
Recommended Citation
Liambila, Wilson, Saumya RamaRao, Joyce Wanderi Maina, and Mary W. Gathitu. 2013. "Mainstreaming
emergency contraception in developing countries: A toolkit for policymakers and service providers."
Nairobi: Population Council.

This Guide/Toolkit is brought to you for free and open access by the Population Council.

MAINSTREAMING
EMERGENCY CONTRACEPTION
IN DEVELOPING COUNTRIES

A TOOLKIT FOR
POLICYMAKERS AND
SERVICE PROVIDERS

WILSON N. LIAMBILA, SAUMYA RAMARAO,
JOYCE WANDERI MAINA, MARY W. GATHITU
JANUARY 2013

The Population Council confronts critical health and development issues—from stopping the spread
of HIV to improving reproductive health and ensuring that young people lead full and productive lives.
Through biomedical, social science, and public health research in 50 countries, we work with our
partners to deliver solutions that lead to more effective policies, programmes, and technologies that
improve lives around the world. Established in 1952 and headquartered in New York, the Council is a
nongovernmental, nonprofit organization governed by an international board of trustees.
Population Council
General Accident House
Ralph Bunche Road
Nairobi
Kenya
Tel: +254 20 271 3480
Fax: +254 20 271 3479
www.popcouncil.org

Suggested citation: Liambila, Wilson N., Saumya RamaRao, Joyce Wanderi Maina, and Mary W. Gathitu.
2013. Mainstreaming Emergency Contraception in Developing Countries: A Toolkit for Policymakers and
Service Providers. Nairobi: Population Council.

ACKNO

© 2013 The Population Council, Inc.

		

TABLE OF CONTENTS

Acknowledgments...............................................................................................................................................................iv
Overview of the Toolkit and Structure.............................................................................................................................. 1
Abbreviations and Acronyms............................................................................................................................................. 2
Introduction.......................................................................................................................................................................... 3
Section A: Conceptual Framework for Mainstreaming EC............................................................................................ 4
Section B: Justification and Guiding Principles............................................................................................................... 5
Section C: Purpose, Target Audience, and Steps Involved............................................................................................ 8
Section D: Institutional Framework and Implementation Mechanism.....................................................................10
Section E: Management of FP/EC Logistics..................................................................................................................11
Section F: Monitoring and Evaluation Activities and Pharmacovigilance.................................................................14
Section G: Summary of Key Lessons and Programmatic Considerations................................................................16
Appendices.........................................................................................................................................................................21
A.1 – Project Overview and Summary of Results........................................................................................................22
A.2 – Health Care Providers Quick Reference Guide...................................................................................................31
A.3 – Selling Protocol for Emergency Contraception Pills..........................................................................................35
A.4 – Job Aid for Bridging EC Users to Other RH Services..........................................................................................37
A.5 – Hormonal Emergency Contraception...................................................................................................................39
A.6 – WHO Fact Sheet on Emergency Contraception..................................................................................................45
A.7 – MOH Monthly Supervision and Monitoring Tool.................................................................................................49
A.8 – Key M&E Indicators for FP Commodities/EC Pills.............................................................................................53

ACKNOWLEDGMENTS

We wish to acknowledge the individuals and a number
of organizations in Kenya who have over the years made
it possible to achieve the results outlined in this toolkit.
In particular we wish to thank the Nursing Council of
Kenya, Clinical Officers’ Council, Division of Reproductive
Health (DRH) in the Ministry of Public Health and Sanitation (MOPHS), Kenya Medical Supplies Agency (KEMSA),
major distributors of EC brands in Kenya, Population Services International, Liverpool VCT Care and Treatment,
Pharmaceutical Society of Kenya, Pharmacy and Poisons
Board, and other institutions including NGOs, CBOs,
partners in the USAID-supported APHIA II program, and
provincial health management teams for having played
different roles during the planning, implementation, and
evaluation phases of the project on mainstreaming EC in
Kenya.
We also wish to acknowledge the Gender Violence
and Recovery Center (GVRC), Kenyatta National Hospital
(KNH), Flame Tree Pharmacy, Liverpool VCT Care and
Treatment, Dr. B. Monda, Lecturer in Ob/Gyn Kenyatta
University and health columnist in women’s reproductive

iv

health issues for having played different roles during the
efforts to ensure sustained impact of the achievements
of the first phase of the project on mainstreaming EC in
Kenya and to the research assistants who meticulously
undertook field work in many parts of Kenya.
Our colleagues in the Council (specifically, Jill Keesbury, Francis Onyango, Benta Owino, Lucy Nganga,
Katherine Maina, and Ian Askew) are acknowledged for
having actively participated in generating the evidence
that has gone into compiling the toolkit. Janet Munyasya
and Teresa Atieno Bange are acknowledged for formatting the toolkit.
This initiative was made possible through the generous support of the William and Flora Hewlett Foundation, which has shown true leadership and vision in
promoting EC across the world. The United Nations
Population Fund (UNFPA) in Kenya also provided technical and financial assistance for work under this initiative,
and has served as an active advocate for EC mainstreaming in the country.

OVERVIEW OF THE TOOLKIT AND STRUCTURE

In late 2006, the Kenyan Ministry of Health (MOH), the
Population Council, and Population Services International (PSI) launched an initiative to mainstream emergency
contraception (EC) in Kenya. The initiative included a
core set of activities aimed at improving overall awareness of emergency contraception across the country
and strengthening the quality of EC services in both
the public and private sectors. It was intended to serve
as a model for other countries interested in improving
access to EC, and to generate in-depth knowledge on
EC program strategies and utilization characteristics in
sub-Saharan Africa.
By the conclusion of the initiative, sales of EC in the
private sector had more than tripled and public sector
utilization also increased tremendously. Overall knowledge among providers increased significantly over the life
of the initiative. Provider capacity also increased in the
private sector through an innovative, noninvasive strategy to improve information provision in pharmacies. Preservice training curricula for nurses and clinical officers
were updated to include EC, and the MOH drew lessons
and experiences from the initiative to substantially revise
the EC component of the 2010 National Family Planning Guidelines for Health Providers (2010) among other
achievements.

Toolkit
This toolkit on mainstreaming emergency contraception
in developing countries has been developed in response
to one of the objectives of the 2006 initiative that sought
to generate lessons that could serve as a model for other
countries interested in improving access to EC, and to
generate in-depth knowledge on EC program strategies
and utilization characteristics in sub-Saharan Africa.
As has been pointed out in many publications, including those produced by the International Consortium on
Emergency Contraception (ICEC), for many women, emergency contraceptive pills (ECPs) offer an opportunity to
prevent unintended pregnancy following unprotected sex

and contraceptive method failure. ECPs are also given as
primary prevention of unintended pregnancy in case of
rape. Hence, timely access to this safe, effective option
remains an essential element of women’s quality reproductive healthcare.
Yet ECPs remain inaccessible in many developing
countries, especially in sub-Saharan Africa where many
factors continue to undermine the ability of women to access and use ECPs. This toolkit is based on a theoretical
framework that was developed from a thorough review
of the available evidence from the EC mainstreaming
activities implemented by the Population Council, MOH,
and PSI.

Audience
The primary target groups for the toolkit are policymakers and health care providers. It can also serve as a
resource for trainers (for both pre-service and in-service
students), researchers, RH program managers, and technical advisors who organize or facilitate training events
and advocacy workshops for emergency contraception
activities, advocates, lay community members, media,
and donors. The toolkit can be used in countries where
ECPs are not currently available, as well as in contexts
where the intention is to expand or mainstream access
to existing ECP services. The toolkit is generic and could
be adapted by countries, institutions, and individual
health care providers wishing to mainstream emergency
contraception services in their respective settings.

The structure
The toolkit is divided into eight sections:
• Section A provides the conceptual framework on
mainstreaming of emergency contraception activities
within the public and private sectors.
• Section B addresses justification and guiding principles.
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• Section C focuses on purpose and steps involved in
mainstreaming EC.
• Section D outlines the institutional framework required to successfully mainstream EC activities.
• Section E discusses effective management of EC
logistics.
• Section F addresses supervision and monitoring
activities.
• Section G focuses on key programmatic considerations; and
• Section H contains appendices, which are the main
products of the EC mainstreaming work.
The appendices appearing in Section H are as follows:
A.1 - Project Overview and Summary of Results
A.2- Health Care Providers Quick Reference Guide
A.3- Selling Protocol for Emergency Contraception Pills
A.4 - Job Aid for Bridging EC Users to Other RH Services
A.5 - Hormonal Emergency Contraception
A.6 - WHO Fact Sheet on Emergency Contraception
A.7 - MOH Monthly Supervision and Monitoring Tool
A.8 – Key M&E Indicators for FP Commodities/EC Pills

The CD-ROM includes:
Some of the bulky reports such as the final EC mainstreaming report, the follow-up project report, and
publications.
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Abbreviations and Acronyms
AIDS
APHIA

Acquired Immuno-Deficiency Syndrome
AIDS, Population and Health Integrated
Assistance
BCC
Behavior Change Communication
BScN
Bachelor of Science in Nursing
CBD
Community-Based Distributor
CHW
Community Health Worker
COC
Combined Oral Contraceptive
CTU
Contraceptive Technology Update
DCMCH Diploma in Clinical Medicine and
Community Health
DHS
Demographic and Health Survey
DMPA Depot-medroxyprogesterone acetate
DRH
Division of Reproductive Health
EC
Emergency Contraception
ECP
Emergency Contraceptive Pill
FP
Family Planning
GBV
Gender-Based Violence
HIV
Human Immuno-Deficiency Virus
ICEC
International Consortium for Emergency
Contraception
IEC
Information, Education, and Communication
IUD
Intrauterine Contraceptive Device
KDHS Kenya Demographic and Health Survey
KEMSA Kenya Medical Supplies Agency
LMIS
Logistics Management Information System
M&E
Monitoring and Evaluation
MCH
Maternal and Child Health
MIS
Management Information System
MOH
Ministry of Health
MOPHS Ministry of Public Health and Sanitation
NGO
Nongovernmental Organization
OTC
Over-the-Counter
PEP
Post-Exposure Prophylaxis
PRC
Post-Rape Care
PSI
Population Services International
RH
Reproductive Health
SGBV
Sexual and Gender-Based Violence
SPA
Service Provision Assessment
STI
Sexually Transmitted Infection
SRH
Sexual and Reproductive Health
TA
Technical Assistance
UNFPA United Nations Population Fund
VCT
Voluntary Counseling and Testing
WHO
World Health Organization

INTRODUCTION

In late 2006, Kenya’s Ministry of Health
(MOH), the Population Council, and Population Services International (PSI) launched an
initiative to mainstream emergency contraception (EC)* in both the private and public
sectors of Kenya. The specific objectives of the

initiative were to: increase knowledge, awareness, and
use of EC among Kenyan women aged 18–30 years;
increase knowledge and awareness of EC among health
care providers; and strengthen EC provision in both the
private and public sectors. When the initiative concluded
in 2009, sales of EC in the private sector had more than
tripled, and public-sector utilization had also increased
tremendously.

Overall knowledge among providers increased significantly over the life of the initiative, and those trained in
EC demonstrated more favorable attitudes and practices
toward EC. Provider capacity also improved in both the
private and public sectors. The results of the project were
disseminated to policymakers, media, donors, and program managers in June 2010. The Council was awarded
a follow-up project for the period January 2010 to September 2012 to institutionalize and sustain the achievements realized under this initiative and to promote the

Kenyan experience as a model for other countries in
sub-Saharan Africa. Thus, the rich experiences gained
and the materials used in mainstreaming emergency
contraception activities within the National Reproductive
Health and Family Planning programs in Kenya, including
the follow-up project, have been compiled into a toolkit
for use by health care providers working in developing
country contexts.
The toolkit is generic and could be adapted by countries, institutions, and individual health care providers
wishing to mainstream emergency contraception activities in their respective settings. The toolkit is divided
into eight sections (A, B, C, D, E, F, G, and H). Section A
provides the conceptual framework on mainstreaming
of emergency contraception activities within the public
and private sectors. Section B addresses justification
and guiding principles. Section C focuses on purpose and
steps involved in mainstreaming EC. Section D outlines
the institutional framework required to successfully
mainstream EC activities. Section E discusses effective
management of EC logistics. Section F addresses supervision and monitoring activities. Section G focuses on key
programmatic considerations while Section H contains
appendices (key products of the EC mainstreaming work).

* Emergency contraception (EC) refers to several contraceptive methods that can be used to prevent pregnancy after sex, including
emergency contraceptive pills (ECPs) and intrauterine devices. They offer women an important second chance to prevent pregnancy when
a regular method fails, no method was used, or sex was forced. ECPs must be taken within 120 hours of intercourse, however, the sooner
they are taken, the more effective they are. Thus, the three types of ECPs are: combined ECPs containing both estrogen and progestin,
progestin-only ECPs, and ECPs containing an antiprogestin (either mifepristone or ulipristal acetate).
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SECTION A		CONCEPTUAL FRAMEWORK FOR
MAINSTREAMING EC

The conceptual framework shown in Figure 1 has been
constructed from the experience and evidence acquired
mainly from 2006 when an initiative to mainstream
emergency contraception (EC) was launched. Available
frameworks (including those developed by FIGO and the
World Health Organization) do not address programmatic
aspects of mainstreaming emergency contraception in
developing countries. Rather, they are confined to aspects such as mainstreaming emergency contraception
within gender contexts or mainstreaming family planning
within sexual and reproductive health (SRH) activities.

The framework shown below highlights the challenges
addressed by the program over the years, project
objectives, interventions carried out, and their effects
or outcomes. Interventions included raising awareness
through the mass media, the use of job aids, IEC materials, weekly updates on EC by retailers, development of
a Quick Reference Guide, engaging leadership in EC
mainstreaming, organizing for pre- and in-service training, and ensuring stock sustainability, among many other
approaches shown in Figure 1.

FigURE 1 Conceptual Framework for mainstreaming emergency contraception
activities at country level
CHALLENGES
• High proportion of
births mistimed
or unwanted
• Use of EC can
reduce unwanted
pregnancies
• Access to EC
limited (low proportion of women
“ever heard” or
“used”)



• Limited capacity
within public and
private sectors
(low proportion
of health care
providers trained
on EC use)

• Pharmacists expressed need for
more information
on EC
• Less than 5%
of health care
providers correctly identified
timeframe for EC
• Misinformation
and negative
media coverage
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OBJECTIVES
Increase
knowledge and
use of EC
among women
aged 18–30



Strengthen the
provision of EC
in the private
sector



INTERVENTIONS

EFFECTS/OUTCOMES
• Awareness and use of ECPs increased
drastically between 2003 and 2009

Raising awareness through:
• Mass media campaign on radio, TV



• Point-of-sale materials in pharmacies
• Community outreach campaigns
• A youth hotline (One2one hotline)

• A youth hotline increased users of EC
services

Private sector interventions included
the use of three simple approaches:

• Sales of 4 major EC brands increased
three times over project life

• Job aids with three key messages in
English and local language



• IEC materials: brochures and posters
• Weekly updates on EC by retailer
Public-sector interventions included:



• Engaging leadership in EC mainstreaming
• Organizing for pre- and in-service
training



• Ensuring stock sustainability
• Strengthening EC in national FP
guidelines

Promote
lessons
learned/
experience
as a model
for improving
access to EC in
the region



• Pharmacy staff improved provision of
basic information on ECPs to clients
• Pharmacy staff can effectively use job
aids to offer quality EC services

• EC can now be obtained at all service
delivery levels

• Use of a Quick Reference Guide
Strengthen the
provision of EC
in the public
sector

• Media campaigns were effective in
disseminating key messages on EC

• Expanded list of persons to dispense
EC including trained CHWs/CBDs
• Trained providers now counsel/provide ECPs and have more favorable
attitudes

• Institutionalizing the EC initiative

• The EC selling/dispensing protocol approved by local pharmaceutical society

• Providing support to the private
sector

• An ongoing South-to-South collaboration

Sustainability interventions included:

• Leveraging additional support for EC



• Using evidence as a model for region

• Previous experience/evidence served
as a basis or model for other countries’ plans

SECTION B		JUSTIFICATION AND GUIDING
PRINCIPLES

Justification
Emergency contraception, sometimes referred to as
“morning after” or post-coital contraception provides a
second chance for women who experience contraceptive
failure or do not use a method, as well as for women who
experience unplanned intercourse, including coerced
sex or rape. Knowledge of emergency contraception
is crucial, since women must know they can prevent
pregnancy after intercourse in order to seek care. While
rates of unwanted pregnancy vary in different countries
and among population groups, the need for emergency
contraception is critical especially in developing countries. Examples of contraceptive failure or incorrect use
are shown in Box 1.
Despite the demonstrated safety and efficacy of
emergency contraception, its acceptance by providers
and the public, and its inclusion on the WHO’s essential
drug list, emergency contraception is not widely available
in many developing countries.1 Contrary to the perceived
benefits of EC, in a recent article Durrance2 concludes
that increased access to EC in Washington State had
no impact on abortion rates and resulted in higher STI
rates (specifically gonorrhea). Similar findings have, in
the past, been challenged by other researchers. For instance, in response to an earlier article published in the

BOX 1

Journal of Health Economics the authors criticized what
they termed a “dubious association” between OTC access to EC and STI rates in the UK.3 The authors argued
that the pharmacy access program itself may have led to
significant increases in rates of STI screening, (through
greater detection of gonorrhea), rather than improved
access to EC leading to riskier sexual behavior. In addition, they also observed that the population-level effect
of EC on abortion rates may be unrealistic, particularly
since many acts of sex are unprotected and EC is not
always used.
Because EC prevents unwanted pregnancies, efforts
to mainstream the method could be justified on the
grounds that its use could be seen as an intervention
to reduce maternal morbidity and mortality associated
with unsafe abortions and other causes. Abortion is a
frequent consequence of unintended pregnancy and,
in the developing world, can result in serious, long-term
negative health effects including infertility and maternal
death. Regardless of the cause, unintended pregnancy
and its negative consequences can be prevented by
access to contraceptive services including emergency
contraception. Addressing unintended pregnancy and its
substantial human and dollar costs should be a priority

Examples of contraceptive failure or incorrect use

• Condom breakage, slippage, or incorrect use;
• Three or more consecutively missed combined oral
contraceptive pills;
• The progestogen-only pill (minipill) taken more than
three hours late (or more than 12 hours late if taking
a 0.75 mg desogestrel-containing pill);
• Norethisterone enanthate (NET-EN) progestogen-only
injection taken more than two weeks late;
• Depot-medroxyprogesterone acetate (DMPA) progestogen-only injection taken more than four weeks late;
• The combined estrogen-plus-progestogen monthly
injection taken more than seven days late;
• Dislodgement, delay in placing, or early removal of a
contraceptive hormonal ring or skin patch;

• Dislodgement, breakage, tearing, or early removal of
a diaphragm or cervical cap;
• Failed withdrawal (e.g., ejaculation in the vagina or
on external genitalia);
• Failure of a spermicide tablet or film to melt before
intercourse;
• Miscalculation of the periodic abstinence method,
or failure to abstain or use a barrier method on the
fertile days of the cycle;
• Expulsion of an intrauterine contraceptive device
(IUD) or hormonal contraceptive implant.
Source: Levine, Ruth, Ana Langer, et al. 2006. “Chapter 57: Contraception,” in Dean T. Jamison et al. (eds.), Disease Control Priorities in Developing Countries, Second edition. Washington, DC: The International Bank
for Reconstruction and Development/The World Bank, pp. 1975–1990.
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in every country. Women and adolescents require access
to age-appropriate and culturally sensitive reproductive
health care services, including emergency contraception which is necessary in order to impact the staggering
maternal mortality rates worldwide.4
In addition to the health-related arguments in favor of
the use of emergency contraception, other researchers
cite other reasons (which are applicable to contraceptives in general). For instance, Levine et al.5 state that
three rationales have underlain policy and programmatic
interest in contraception, since the 1960s:
• The demographic rationale, typically framed around
lowering the rate of population growth to achieve
broad economic, social, and environmental aims, was
most prominently applied in the 1960s and 1970s.
By helping to avoid unplanned pregnancies, use of
emergency contraception contributes to this rationale.
• The fertility rationale, which emerged in the 1980s,
promoted lower fertility under the assumption that
smaller families are better off in terms of economic
and health conditions.
• The human rights rationale, which surfaced in 1994
at the International Conference on Population and
Development in Cairo, served as a major force in the
1990s to focus attention on women’s rights to autonomy and empowerment in childbearing and on female
and male reproductive health. The Cairo Program of
Action stressed the political and cultural dimensions
of contraception, including gender issues. In many
countries, health policies and constitutional provisions stipulate and confer the citizens’ fundamental
rights to enjoy the highest standards of health care
including reproductive health. The choice regarding
whether or not to have children, when to have them,
or to postpone is part of the broad range of choices
that exist under the human rights rationale.
In addition, published evidence demonstrates convincingly that making ECPs more widely available does
not increase risk-taking or adversely affect regular contraceptive use.6 In the four studies that examined the impact of easier access to ECPs on rates of sexually transmitted infections, women randomly assigned to a group
given advance supplies of ECPs for later use should the
need arise had the same incidence of infection as did
women in the control group who had to obtain ECPs from
a clinic. For example, in one randomized trial considering
the effect of advance ECP provision on regular methods
of birth control, teens receiving emergency contraception
supplies in advance were more likely to use ECPs when
needed but did not report higher frequencies of unprotected sex, did not use condoms or hormonal contraception less often, and did not exhibit higher rates of STIs.7
Another study demonstrated that educating teens about
ECPs does not increase their sexual activity levels or use
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of EC but increases their knowledge about proper administration of the drugs.8
From a global perspective, EC has yet to reach its full
potential: many remain unaware that the option exists
and EC remains difficult for most women to access in a
timely fashion. Much work still remains to ensure that EC
is available, especially in developing countries, and that
unreasonable prescription requirements are re-examined. Evidence from recent demographic and health
surveys in sub-Saharan Africa shows that contraceptive
use is still low and that:
• A high proportion of births (up to 50 percent) are
mistimed or unwanted.
• A low proportion of women have “ever heard” or
“used” EC. For instance, only 40% of women in Kenya
have ever heard of EC and 1.7% had ever used EC.9
• There is a limited capacity within public and private sectors for counseling about EC and correct provision (low
proportion of health care providers trained on EC use).
• Misinformation and negative media coverage persist, leading to misuse and stigma among those who
request a method of EC.

Guiding Principles
Guiding principles for the improvement of health in
general, and SRH in particular, have been adopted or
reconfirmed at international assemblies and conferences
and laid down in international documents including the
Report of the International Conference on Population
and Development (Cairo, 5–13 September 1994); and
the “Overall Review and Appraisal of the Implementation
of the Program of Action of the International Conference
on Population and Development,” presented to the General Assembly of the United Nations, 1 July 1999.10
Principles that have guided the development of the
toolkit are:
• Health is a fundamental human right. Everyone has
the right to the highest attainable access to health
care services, including those related to reproductive health care, which includes family planning and
sexual health.
• Commitment to the ethical concepts of equity, solidarity, and social justice and to the incorporation of a
gender perspective in SRH strategies by policymakers, program managers, providers, and other implementers. This includes solidarity in action between
countries, between groups in countries, and between
sexes.
• Ensuring that all health services are based on scientific evidence, of good quality, and within affordable
limits, and that they are sustainable for the future.

• All couples and individuals have the basic right to
decide freely and responsibly the timing, number, and
spacing of their children and have access to information and education in order to ensure optimal health
and informed decisionmaking.
• All people have the right to decide freely and responsibly on all aspects of their sexuality, and have the right
to be free from conditions that interfere with sexual
health; sexually acquired conditions including sexually transmitted infections (STIs) and HIV/AIDS; and
coercion into having sex and other forms of sexual
violence.
• The process of initiating emergency contraception
should be participatory with a broad selection of participants or stakeholders.
• The toolkit acknowledges that ECPs are a back-up
method for unprotected intercourse or contraceptive method failure and, as such, represent one of a
range of contraceptive methods available to national
programs. Therefore, the introductory process should
ensure that ECPs are included in the program’s overall training materials as well as in the logistics and
distribution systems.
• Reproductive health care must be responsive to
expressed needs of the consumers. Individuals have
both rights and responsibilities in promoting their own
health and development. Similarly, governments have
responsibilities for stewardship in the provision of
health services.
• The provision of reproductive health services is enhanced by policies and programs that promote gender
equity and equality, empower women, integrate the
provision of RH/HIV services, and eliminate all forms
of gender-based violence and discrimination.

• Gender equity and equality must be addressed at all
levels of service delivery, including generating and
sharing information and in monitoring and evaluation
(M&E) activities. Involvement of men as RH consumers and responsible partners to women will increase
access to and use of RH services, including prevention of unintended pregnancy.
• There are many providers of EC services besides the
Ministry of Health (MOH) and its agencies. These include chemists and pharmacies in the private sector,
NGO and FBO facilities, other departments of government such as the police (e.g., Zambia, South Africa).
Efforts to improve EC provision within countries
should consider all the potential stakeholders.
• The conceptual framework for mainstreaming EC
activities is not prescriptive; rather it allows each
country to freely make adaptations to it based on
the local reproductive health policies and regulatory
framework.
• Given that the use of emergency contraception
provides a second chance to women who have had
unprotected sex, policymakers, program managers,
regulatory authorities, pharmacy staff, and other
health care providers should strive to minimize all barriers that could prevent women from accessing and
using these pills and other products for EC. Given that
the method using pills is controlled by the woman,
this autonomy should be respected by society through
user-friendly information materials and services.
• Introduction of EC mainstreaming activities and rollout should be coordinated and integrated with other
services and programs to capitalize on existing infrastructure and program efforts especially in the public
sector.
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SECTION C		PURPOSE, TARGET AUDIENCE, AND
STEPS INVOLVED

The toolkit is designed to assist policymakers, program
managers, and health care providers identify the most
strategic opportunities for introducing EC mainstreaming activities in their respective settings and preferably
within existing RH/FP programs. This toolkit is not designed as a detailed assessment tool. Numerous excellent assessment guides and programming tools have
been developed to design EC programs and services, in
the context of larger family planning programs and GBV
activities. Most of these tools are available from the ICEC
(www.cecinfo.org), Princeton University (ec.princeton.edu/
emergency-contraception.html), and the Population
Council (www.popcouncil.org).

Intended Audience
Below is an illustrative list of potential country-level
stakeholders to be involved in the process of mainstreaming emergency contraception:
• Policy decisionmakers and program planners
• Program managers, supervisors, providers of various
RH services
• Managers of commodity security and logistics
• Key training institutions
• NGO, faith-based, private, and professional organizations, particularly those focused on family planning
and other reproductive health activities
• Women’s advocates and advocates for vulnerable
populations
• Institutions involved in social marketing or other communication initiatives
• Development partners, including donors and technical
assistance agencies
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• Pharmaceutical societies
• Regulatory boards or councils responsible for drug
registration and pharmacovigilance activities
• Private sector pharmaceutical distributors
• Representatives of chemists and pharmacies
• Producers of EC products
• Health care providers responsible for services designed to reach young people (girls/young women
particularly), including school and university-based
health clinics.

Steps Involved in Mainstreaming
EC Services
Following proper steps is key to successful development and implementation of emergency contraception
mainstreaming activities. Any country or subnational
entity wishing to develop an emergency contraception
program should be guided by the following steps or
process activities: Preparation and awareness-creation,
rapid assessment, sharing findings and reaching consensus on priorities, and developing a plan of action. Other
steps include developing health system tools, training
providers, introducing emergency contraception pills
(ECPs), monitoring and supervision, program review and
evaluation, dissemination of results, and scaling up and
strengthening program sustainability. These steps are
detailed in Table 1 below. Although the steps are organized chronologically, several actions within each broad
step do overlap and may also be revisited over time.

TABLE 1 Steps for developing and mainstreaming an emergency contraception program
KEY STEPS

DESCRIPTION OF THE STEPS

A. Preparation, advocacy,
and creation of awareness

This step involves organizing meetings of key persons or officials in the departments responsible for reproductive health matters including FP and those responsible for registration and regulation of drugs as well as
distribution of FP commodities. The purpose of this step is to agree on the main issues and next steps

B. Rapid assessment

Rapid assessment of emergency contraception service needs, regulatory requirements, and service delivery
capabilities among other things is a critical step in the provision of information to guide the mainstreaming
plan for an EC program. Important activities during the assessment include:
• Identifying factors that influence patterns of choice and potential use of ECPs in both public and private
sectors;
• Understanding user perspectives on ECPs and the service delivery system;
• Identifying the service delivery and managerial adaptations necessary to provide quality ECP services;
• Assessing providers’ knowledge, attitudes, and practices on EC; and
• Using the outcomes of these activities to develop national strategies for the introduction and subsequent
widespread availability of ECPs.

C. Sharing findings and
reaching consensus
on priorities

Involving a broad range of stakeholders to participate in sharing the results of the rapid assessment is an
important strategy for cultivating ownership. For instance, the pharmaceutical society could make presentations on findings from the private sector while government officials could make presentations on findings from
the public sector facilities.
Findings on user perspectives could be presented by a research institution. This participatory approach also
presents a good opportunity for identifying various skills among in-country teams. A key step in consensusbuilding is for the in-country team to choose the type of EC pill such as Postinor 2 and discuss procurement
plans. In-country teams are advised to choose products that are already registered in the country.

D. Developing a plan of
action

After reviewing the findings from the rapid assessment, the next logical step for the in-country teams is to
develop a plan of action based on the agreed priority activities. In-country teams are encouraged to review the
conceptual framework (Figure 1) so as not to overlook any sector that is crucial in mainstreaming EC.

E. Strengthening health
system tools (e.g.,
registers, stock cards,
others)

In order to track progress regarding the mainstreaming of EC, existing tools—e.g., family planning registers,
stock cards, reporting forms—will have to be modified or redesigned to incorporate additional columns that
health care providers will use to enter EC-related data. This step should also include the development of job
aids or mass media messages for clients on how to use ECPs and where to obtain them, among others.

F. Training providers

Providers will need training in issues related to the provision of ECPs, including the special counseling needs
of ECP clients. Of key importance is ensuring that providers treat women respectfully and maintain a nonjudgmental attitude while providing services. The training related to ECP service delivery provides an opportunity
to strengthen provider knowledge and skills concerning other contraceptive methods; the importance of their
routine use; and sexually transmitted infections (STIs/HIV risk) assessment, diagnosis, and management.
Information on ECPs must also be incorporated as part of overall training on family planning, including all
basic and refresher training for service providers. It must be stressed in all training activities, however, that EC
does not protect against STIs/HIV or subsequent unprotected intercourse.

G. Introduction and
distribution of ECPs

This step focuses on introducing ECPs into the market and distributing them through acceptable or authorized channels so as to reach clients. In addition to the normal family planning program service delivery
points, such as MCH/FP clinics and community-based distribution systems, the distribution of ECPs should be
considered through a variety of other channels. These include private health practitioners, hospital emergency
rooms, pharmacies, social marketing programs, school or university-based clinics, and sexual assault crisis
centres.

H. Monitoring and
supervision

Monitoring and supervision should be conducted routinely to assess key components of the program including
the functioning of the logistics system, provider activities, whether users are accessing ECPs, and emerging
challenges, among others.

I. Program evaluation

Evaluation activities should include assessments of user and provider perceptions and experiences with ECPs
and of the service delivery channels through which they are being provided. Evaluation activities can assist in
ensuring that ECPs are used appropriately and serve as a bridge to regular FP for clients who require it.

J. Dissemination of
results

•

The evaluation results should be disseminated to a broad group of stakeholders.

•

The results should form the basis of developing strategies for scaling up EC provision with emphasis on
the need to enhance quality EC services.

K. Scaling up and
strengthening program
sustainability

In-country stakeholders will, on the basis of evaluation results, plan for the scale up of EC mainstreaming activities in other parts of the country so as to increase national coverage. Such a plan has to be agreed upon by
many stakeholders given its financial and administrative implications.
The interest of in-country stakeholders including MOH in sustaining EC activities is to ensure that current program activities and the proposed ones together with the benefits they produce are continued long after the
initial funding would have stopped, especially from development partners. Hence the need for in-country teams
to develop sustainable FP programs including EC. Such programs should consider taking into account factors
such as the need to provide high-quality services, providing management support for activities such as planning
and supervision, ensuring broad-based commitment by policymakers and public–private partnerships which
are critical elements in ensuring EC program sustainability.
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SECTION D		INSTITUTIONAL FRAMEWORK AND
IMPLEMENTATION MECHANISM

Many countries have three levels of health care management and coordination. These are national, regional, and
district levels. The national level is responsible for policy
and stewardship, the regional level is usually responsible
for coordination, training, and quality assurance while
the district level is responsible for managing implementation. Delivery of health care services also happens at the
service delivery point and at the community level.

Successful mainstreaming of EC activities at the
country level has to take into account the potential role
of national, regional, and district levels and in particular
how these levels will play complementary and supportive
roles to each other. These roles are outlined below in
Table 2 with regard to emergency contraception mainstreaming activities.

TABLE 2 Roles of various institutions in mainstreaming emergency contraception activities by level of health care management and coordination
NATIONAL LEVEL

REGIONAL/PROVINCIAL/
COUNTY LEVEL		

DISTRICT/COMMUNITY LEVEL

• Develop reproductive health policies

• Supervise

• Facilitate identification of providers dispensing ECPs

• Provide leadership, advocacy, and coordi-

• Monitor

• Assess premises that stock ECPs

• Train

• Organize capacity-building and continuing

nation of reproductive health activities at
all levels and among stakeholders.
• Establish procedures, and adopt required
regulations, standards, and guidelines
• Disseminate and distribute policy briefs
and discussion papers on emerging EC
mainstreaming issues
• Advocate for increased funding for RH
including family planning activities
• Assess the safety, efficacy, and quality of
drugs and medical devices
• Lead/coordinate/monitor and evaluate EC
mainstreaming activities
• Organize periodic forums for disseminating results and experiences
• Develop training curriculum manuals and
advocacy materials on EC for distribution
at subnational levels

• Quality assurance
• Coordinate monitoring
and evaluation of EC
mainstreaming activities
• Disseminate national
guidelines, policies,
standards, among
others
• Carry out pharmacovigilance activities
• Organize periodic forums for disseminating
results and sharing EC
mainstreaming activities in the region

professional development/in-service training
• Ensure re-supply of ECPs and other family planning
commodities
• Provide supportive supervision to health facilities
• Mobilize local resources to support RH/FP activities
• Compile monitoring data and produce periodic reports
• Review community level IEC/BCC materials for
relevance and appropriateness
• Facilitate dialogue between community and health
service providers
• Strengthen community involvement in decisionmaking
about EC services
• Establish a link between the health sector and the
community
• Identify cultural beliefs and practices that influence
health care–seeking behavior
• Quantify requirements for FP including ECPs and
place requisitions as per national schedules and
requirements
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SECTION E		MANAGEMENT OF FP/EC LOGISTICS

Proper management of any logistics system is to ensure
that goods including ECPs or services such as counseling
or information and education reach the intended clients
at the right time and place. Key messages that are appropriate to many logistics management systems including the delivery of ECPs are outlined Text Box 2.

Components of inventory
management
Implementation experience has demonstrated that managers involved in procuring, storage, and distribution of
FP/RH commodities including ECPs need to pay attention

BOX 2

to the following components of inventory control:
• Determining supply needs (explained below)
• Receiving
• Storing
• Issuing
• Recordkeeping

Determining Supply Needs
Determining supply needs is one of the most important
steps in inventory management.

Key messages for effective logistics management system for ECPs*

• The logistics six rights provide that good logistics
deliver: the right product, in the right quantity, in the
right condition, to the right place, at the right time, and
for the right cost. The “right logistic management information system” to enable the delivery of the six rights
possible could be considered the seventh right.
• The purpose of a logistics management information
system is to collect, organize, and report information
to other levels in the system in order to make decisions regarding the quantity and the time needed to
distribute drugs, contraceptives, and related medical
supplies.
• Procurement, recording, and reporting are important
functions of any logistics management system
• All personnel at all levels are important in making the
logistics system work effectively.
• An effective logistics system will ensure that facilities
are adequately stocked at all times and that medical
supplies including ECPs are available when needed.
If staff carry out their responsibilities to the best of their
abilities, then the seven “rights” will be achieved.

Components of a Logistics System
• Serving the customer
• Product selection
• Forecasting and procurement
• Inventory management
• Logistics Management Information System (LMIS)
• Continuous monitoring

Items that any logistics management information system needs to capture are:
• Stock on hand: quantities of usable stock at any level
of the system (or facility) at a particular point in time.
• Consumption data: the quantity of commodities dispensed or used during a particular period of time.
• Data on losses and adjustments: the quantity of
commodities no longer available for use, which have
not been dispensed/used (e.g., damaged, expired, or
stolen commodities), and transfers to or from other
facilities.
*Source: Ministry of Health. 2008. Integrating Counselling and Testing for HIV into Family Planning Services, National Training Manual,
1st Edition. Nairobi: Ministry of Health. March.
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Once the necessary supply needs are identified and
quantified, the next step is to reconcile these requirements with the available financial resources or budgetary
commitment (from either the government or donors).
Once this is done then appropriate procurement
processes are undertaken to facilitate the delivery of the
commodities. More often the quantities of commodities
procured under a public-sector program are dependent
on the availability of financial resources allocated for this
purpose by ministries of finance. The situation is slightly
different in the private sector where the quantities procured or distributed are dependent on potential demand
for the respective commodity or commodities.
Determining supply needs is done by conducting a
physical inventory in order to review stock status. Other
reasons for conducting a physical inventory include:
• Determining how much of each commodity one has in
the facility,
• Determining how long the stocks will last, and
• Ascertaining whether the available quantities of
stocks could last until the next order is received or
processed.
Frequent review of stocks is important in estimating
consumption of commodities and supply needs. Estimating consumption of commodities is done as follows:

control, and distribution of FP/RH commodities including ECPs need to be conversant with basic concepts
concerning months of stock and how to derive maximum and minimum levels of stocks at different levels
of inventory control. This is because central, regional, or
district and health facilities require varying quantities of
minimum and maximum months of stock.

Months of stock
This is the number of months supplies will last based on
the present consumption rate. It is obtained by dividing
the ending balance per month of stock (e.g., of ECPs) by
the average consumption of stock (e.g., ECPs) per month.

Maximum months of stock
It is the largest amount of each commodity a facility
should hold at any one time.

Minimum months of stock
It is the least amount of each commodity a facility should
have at any one time.
Examples of the minimum and maximum months of
ECPs by level of inventory control are given in Table 3. For
purposes of illustration, only two levels are given, namely
the central warehouse and the health facility.

• Calculate average monthly consumption

Stock card

• Determine months of stock on hand

A stock card or, as it is sometimes called, a bin card is
an important document that records the status of a good
or goods held in a store or stockroom. The card helps
in recording a running balance of stock (in our case the
ECPs). Thus, the stock card (see an example in Figure 2)
facilitates accounting for supplies requisitioned. In places where information is not computerized, it is stored at
the service delivery point and is completed by the officer
in charge each time new supplies are received. In places
where inventory control has been computerized, the
information on the stock card is updated electronically
and it is possible to know the balance of the stocks on
daily basis.

• Determine order quantity (by estimating maximum
and minimum stock levels, conducting physical
counts [stock on hand] and subtracting the balance
on hand from the maximum stock level to be able to
obtain the quantity to order).

Monitoring Monthly Consumption of
ECP Stocks
Monitoring monthly consumption of stock is an important step in establishing the quantity consumed or to be
ordered. Managers involved in procurement, inventory

TABLE 3 Minimum and Maximum Months of ECPs by Level of Inventory Control
COMMODITY

Contraceptives
(ECPs)

LEVEL OF
INVENTORY CONTROL

MAXIMUM MONTHS
OF STOCK

LEVEL OF INVENTORY
CONTROL

MINIMUM MONTHS OF
STOCK

Central warehouse

12–15 months

Central warehouse

6–9 months

Health facility

4–6 months*

Health facility

2–3 months*

* Shorter periods of minimum and maximum months of stock are required to avoid possible losses, e.g., through expiry.
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FIGURE 2 EXAMPLE OF A STOCK CARD
Item name:
Manufacturer:
Kit lot number:
Date

Received from

Unit:
Expiration Date:
Issued to

Quantity
received

Quantity
issued

*Balance

Lot #

Signature

*Balance – perform physical inventory count each month. If physical count does not equal balance, consider causes for discrepancies, e.g., theft,
expired drugs.

Supervision
Effective supervision is a critical element of an effective
Logistics Management System (LMS). Without it, overall
quality of LMS may weaken, which in turn may jeopardize the quality of service provided to clients. This is the
process of ensuring that personnel have the knowledge
and skills required to carry out their responsibilities
effectively, and to provide immediate on-the-job training, as needed. Supervision ensures personnel have the
knowledge and skills they need to effectively manage
the logistics system and identifies performance weaknesses and improves performance through on-the-job
training as needed.
Supervision also ensures that that established logistics guidelines and procedures are being followed. The

team carrying out supervision activities should establish
that each FP service delivery site including clinics and
health posts shall:
• Have a copy of the policy guidelines and service
standards for sexual and reproductive health. Some of
these policies also address the provision of EC services.
• Have a copy of family planning procedures guidelines
for service providers. National FP guidelines usually
address issues to do with the provision of EC services.
• Maintain adequate and accurate records of clients
and commodities.
• The monthly supervision and monitoring tool for ECPs
is found in Appendix A.7.
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SECTION F		MONITORING AND EVALUATION
ACTIVITIES AND PHARMACOVIGILANCE

Monitoring and Evaluation Activities
Efforts for mainstreaming emergency contraception
are likely to be undermined by two main challenges.
First, monitoring the use of emergency contraception
pills by clients in the private sector (including chemists, pharmacies, and clinics) is a difficult task since
the majority of providers do not maintain good records.
Second, monitoring the use of emergency contraception
pills in the public sector is sometimes difficult due to
low volume used coupled with poor reporting rates by
health facilities.
In some countries, FP commodity utilization register(s)
and gender-based violence registers are the main sources of data on ECPs in the public sector. In some countries, the police department or other office in the justice
system could also serve as a source of data for ECPs,
especially those stocks used for gender-based violence
cases. In countries where CHWs/CBDs are allowed to
distribute ECPs, one could also find utilization data from
their records. In the private sector, good estimates of the
use of ECPs at the population level have been derived
from sales data (obtained from the distributors of brands
of dedicated ECPs such as Postinor 2).11
The most likely sources of data for program evaluation are:
a) Demographic and Health Survey (DHS): The DHS is a
nationally representative household survey that is the
source of impact and outcome indicators.
b) Service Provision Assessment (SPA): The SPA is a
nationally representative facility survey that collects
information on aspects of out-patient primary care
(i.e., antenatal, family planning, and sexually transmitted infections) services and providers.
c) Surveillance: Surveillance is the ongoing, systematic collection, analysis, and interpretation of data
on a disease or health condition from public health
programs, combined with feedback to all. It is vital for
guiding the national response.
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d) Evaluations: Evaluations are conducted to gather
evidence on whether the right interventions are being
(or were) implemented with recommendations/lessons learned and whether the program effects could
be attributed to specific interventions.

Pharmacovigilance
Pharmacovigilance refers to the science of collecting,
monitoring, researching, assessing, and evaluating
information from health care providers and patients on
the adverse effects of medicines, biological products,
herbals, and traditional medicines. Pharmacovigilance is
an arm of patient care whose aim is to promote patient
safety by identifying new information about hazards and
preventing harm to patients. Its scope includes substandard and counterfeit medicines, medication error reporting, adverse interactions of medicines, etc. Although this
activity is usually conducted by regulatory authorities,
our implementation experience shows that dealing with
counterfeit ECPs has often required team effort by stakeholders involved in EC mainstreaming work.

Signs of a poor-quality medical product
Identifying and dealing with counterfeit ECPs (especially
the dedicated brands) is often a complex exercise.
However, regular surveillance activities by a team from
regulatory authorities, law enforcement officers, and
public health officials, among others, are often effective
in minimizing this problem.
Box 3 provides a list of examples of signs of a poorquality medical product that does not meet the required
quality standards in terms of physical appearance, level
of active ingredients, packaging, and labeling which the
surveillance teams are likely to look for. Other measures
such as officials from regulatory bodies (in a country
where new ECPs are to be registered) visiting manufacturing sites to assess whether the firms involved do
follow strictly good manufacturing practices and periodic
changes to packaging materials and instructions help in
addressing quality concerns.

BOX 3 Signs of a poor-quality medical
product
Color changes
Separating of components
Powdering/crumbling
Caking
Moulding
Change of odor
Mislabeling
Incomplete pack
Suspected contamination
Questionable stability
Defective components
Poor packaging/poor labeling
Therapeutic failures (lack of efficacy)
Receiving expired medicines
WHO. 2002. The Importance of Pharmacovigilance - Safety monitoring of
medicinal products. Geneva: WHO.

Indicators for Assessing Performance
of FP/ECPs Logistics System
In 2007, the RH Supplies Coalition developed a Monitoring and Evaluation Framework 2007–2015,12 which
contains a list of 30 key indicators for tracking progress
for RH supplies. In this toolkit, some of the indicators
have been adapted for use by countries wishing to track
the EC mainstreaming work. See Appendix A.8 for a full
list of the indicators, which are organized around specific
objectives and the following three goals:

Goal 1: Increase predictability and sustainability of financing for FP/EC supplies
Through this goal, the RH partners, including MOHs aim
to increase resource flows for FP commodities including EC supplies from all sources at the country level.
Possible sources include donors, consumers, the public
sector, insurance schemes, and the private sector.

Goal 2: Strengthen the capacity of health
systems to sustain FP/EC supplies
This goal aims to maximize synergies among MOH partners in order to strengthen supply chain systems and ensure sustained delivery of a broad range of RH supplies
including FP commodities. Strengthening the capacity of
health systems to deliver FP/EC supplies will encompass
both public and private sector institutions.

Goal 3: Steer EC mainstreaming activities
within the broader RH services
This goal seeks to reinforce the capacity of the MOH
and its partners to advocate for RH supplies security
(including FP/EC commodities), promote innovation and
an all-inclusive approach in creating awareness, and in
conducting advocacy activities. The goal also seeks to
expand the total market for FP commodities including EC
pills and identify other sustainable ways of mainstreaming EC such as training, policy support, creating awareness at all levels, and integrating EC mainstreaming in
the broader RH activities.
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SECTION G		SUMMARY OF KEY LESSONS AND
PROGRAMMATIC CONSIDERATIONS

Awareness and Use of ECPs Increased
During the Project Period
Awareness and reported use of ECPs increased dramatically over the life of the initiative. In 2003, the KDHS indicated that less than one quarter of Kenyan women had
ever heard of ECPs.13 In 2007, PSI conducted a baseline
survey in 13 major towns and peri-urban areas across
seven provinces, and found similar patterns, with only
21% of women reporting having ever heard of ECPs and
5% who had ever used the method. Of those, only 15%
could correctly identify ECPs as a contraceptive method
taken after sex to prevent pregnancy. By 2009, 56% of
women in the same sites had ever heard of ECP and 10%
had ever used the method.14
Despite huge increases in the proportion of clients
who had heard of or ever used ECPs, the overall utilisation rate is still low, indicating the need for continued
education and awareness-creation. Countries wishing to
implement EC mainstreaming activities need to appreciate the fact that a major restriction on women’s use of
EC is their very low rate of awareness of this FP method.
Because EC is generally accessed at the pharmacy level
in Kenya women must know about it in order to seek it
out. In this regard, EC differs significantly in the commodity and supply chain issues from other methods such as
implants and female condoms which are described in
detail by the United Nations Commission on Life-saving
Commodities for Women and Children.15
The results are consistent with views recently expressed by Westley and Swartz16 who pointed out that
EC has yet to reach its full potential in terms of impact.
EC remains difficult for most women to access in a timely
fashion, and the most effective methods of EC such as
dedicated ECPS are even harder to access compared to
Yuzpe methods. Dedicated ECPs are effective in preventing up to 95% of pregnancies, and the Yuzpe method is
effective in approximately 75–80% of cases.

Mainstreaming the Provision of EC in
the Private Sector
Findings from the EC mainstreaming project in Kenya
showed that private-sector pharmacies are the most
common access point for ECPs. PSI’s 2007 baseline
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survey found that 94% of women who had used ECP
in the past two years obtained it from pharmacies. In
2009, their endline survey found that while 83% identified pharmacies as a place to obtain ECPs, only 25%
mentioned government clinics.17 In 2008, national-level
ECP distribution through private sector pharmacies was
approximately twice that distributed through the public
sector. Within government clinics, a 2007 record review
found that 93% of the ECPs distributed in the previous
18 months were for sexual assault cases.18 This shows a
possible bias toward the use of EC in cases of sexual assault when compared to other more common indications
that exist within many public health facilities.
In countries where the coverage of the private sector
is not significant in health, such biases in the provision of
EC services by the public sector may imply that women
wishing to have access to it may not succeed because
of the limited options other than in cases of sexual
assault. Therefore, countries wishing to embark on EC
mainstreaming activities need to plan carefully well in
advance on how to position ECPs to avoid stigmatizing
this critical service.
Given the key role pharmacies play in the provision of
EC services, evidence shows that when pharmacy staff
are given basic information on key messages they need
to give their clients, they did provide the information on
EC (including when and how to use it, mechanism of action, side effects, and efficacy). The pharmacy staff also
discussed other FP and RH services with clients. These
results suggest that sales staff at private sector pharmacies can deliver more effective EC services when given
the proper tools. It also indicates that extensive and
often costly training efforts are not needed to improve
services within pharmacies.19

Strengthening the Provision of EC in
the Public Sector
Four main lessons emerged from the implementation experience in mainstreaming EC activities in Kenya. These
lessons (highlighted below) revolve around developing
simple-to-use reference materials for health care providers, integrating ECPs into pre-service and in-service training programs, advocacy activities at the policy level, and
strengthening of data-capture tools (registers).

Materials development for health care
providers
To support training efforts, a comprehensive PowerPoint
presentation on EC was developed for trainers as well
as a booklet, the Health Care Providers Quick Reference Guide, published as part of a strategy to enable as
many health care providers as possible to have access
to user-friendly and updated materials on emergency
contraception. The booklet was also disseminated widely
to provincial and district health management teams by
the MOH and was used as source material for the 2010
update of the National FP Guidelines. Simple and easy-touse materials—especially those that fit into pockets of lab
coats—are preferred by health care providers. Because of
its simplified language, the MOH in Kenya also distributed
thousands of copies of the Health Care Providers Quick
Reference Guide booklet to members of the public.20

Integrating ECPs into pre-service and
in-service training programs
With minimal resources, modules on ECPs were inserted
into in-service training packages for use by health care
providers in Kenya. In addition EC modules were incorporated into the Nursing Council’s and Clinical Officers’
pre-service training curricula. Incorporating EC into the
pre-service training curricula ensures that all future
nursing and clinical medicine graduates will receive
instruction on ECPs and the strategy was seen as a more
cost-effective way of sustaining health care providers’
knowledge and practice on emergency contraception.
The approach also promotes the principle that EC should
be addressed in the context of comprehensive FP/RH
services rather than as a stand-alone service.

Policy-level advocacy is necessary to ensure
adequate ECP stocks in the public sector
Under the leadership of the MOH, advocacy efforts
ensured that ECPs were included in the national contraceptive security plan and subsequent procurements.
For instance in FY 2012/2013 the Government of
Kenya has allocated approximately Kshs. 976,423,000
($11,624, 000)21 for the procurement of FP commodities, which is slightly over twice the amount of funds
(Kshs. 350,000,000=$5,147,059)22 that was allocated
by the Kenyan government for the purchase of FP commodities during FY 2006/2007 at the beginning of the
EC mainstreaming activities. These figures demonstrate
the Kenyan government’s commitment to sustaining the
procurement of FP commodities using its own funds.

Revision of FP registers and inclusion into
the Contraceptive Security Strategy
In 2008 the Division of Reproductive Health (DRH) in the
MOH added a column for ECPs to the revised FP register

to improve recordkeeping and allow facilities to reorder
ECPs. Integrating EC into the documents that underpin
contraceptive security such as the national FP register,
ensured that EC utilization was properly recorded and
captured in facility-level stock re-ordering alongside the
other regular FP methods. Another important accomplishment regarding the EC mainstreaming effort was the
inclusion of ECPs in the national contraceptive security
strategy, which is intended to limit stock-outs of essential family planning commodities. This ensures that EC
programming activities receive the requisite attention at
all levels alongside the other regular FP methods.

Ensuring Sustained Impact
Although PSI’s advocacy campaign was successful in
generating momentum around EC, at the end of the first
phase of the EC mainstreaming project (2007–2009),
stakeholders in Kenya felt that they still required technical assistance in developing strategies to institutionalize
and sustain the achievements realized under this initiative. It was on the basis of this request that the Population Council, with support from the Hewlett Foundation,
coordinated the second phase of the EC mainstreaming
project (January 2010 to May 2012) with a focus on institutionalizing key activities to sustain the impact of the
project. A detailed project description for the follow-up
phase is found in the CD-ROM. Some of the key achievements during the follow-up project were:
• Inclusion of EC into the Bachelor of Science in Nursing
(BScN) syllabus in 2010. The BScN syllabus is administered by the Nursing Council of Kenya. In 2011, the
curriculum for the Diploma in Clinical Medicine and
Community Health (DCMCH) that is administered by
the Clinical Officers’ Council was revised to incorporate new topics including EC.
• Strengthening the provision of EC in public-sector
health facilities by provincial and district level health
management teams through structured support supervision visits.
• Approval of the EC selling protocol, in February 2011,
by the Pharmaceutical Society of Kenya (PSK), for
use by their members to strengthen provision of EC
services in the private sector pharmacies.
• Successful completion of a South–South technical
exchange visit that involved four sub-Saharan African
countries that were interested in mainstreaming emergency contraception activities. The three-day visit took
place in early April 2012 and involved health managers from Rwanda, Malawi, Uganda, and Zambia.
During the meeting, delegates shared experiences in
mainstreaming EC in their respective countries with
their Kenyan counterparts. The teams also visited
private-sector pharmacies (to see how ECPs were
provided in the private sector) and the Kenya Medical
Supplies Agency (KEMSA) to familiarize themselves
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with procurement procedures for FP supplies including ECPs, storage, and countrywide distribution of
these commodities to health facilities.
• The national communications campaign undertaken by PSI effectively increased awareness of EC
among the target population. To expand the program’s impact with limited resources, the Council
worked with the MOPHS to ensure that EC messages are incorporated within the national communications strategy and that the materials from PSI’s
national mass-media Tulia campaign continue to be
used by the MOH.
Besides these achievements, ensuring a sustained
impact of EC mainstreaming activities also requires
that countries focus on the 5Ps of product, price,
place, promotion, and people so that their product (or
service) appropriately targets the chosen segment of
the market.23

Product. How the product (or service) should

channels are used to encourage consumer uptake
of the product or service. PSI used a mass-media
campaign on the radio, in print, and on TV (to increase
awareness and knowledge of EC). In addition, other
channels included developing point-of-sale materials,
e.g., brochures to increase clients’ knowledge and
uptake of regular FP methods).

People. People need to bring products to customers or clients. The revised National FP Guidelines in
Kenya26 allow various cadres of health care providers
to handle ECPs. These include doctors, nurses, clinical
officers, pharmacists, pharmaceutical technologists,
pharmacy assistants, counselors, and community
health workers, among others. For successful institutionalization and replication of EC mainstreaming
activities, as a minimum, each of the persons involved
in providing EC services to clients ought to emphasize
these key messages:

look and function to meet the needs of the target
audience(s). This includes considerations of packaging, branding, and product formulation. Dedicated
EC products are specifically identified for emergency
contraception and contain appropriate instructions as
well as the required number of pills for their correct
use. Specific packaging makes them easier to supply
through pharmacies and social marketing programs.24

• EC can prevent pregnancy after unprotected sex,

Price. What the product (or service) costs the direct

Target-group knowledge, attitudes, and
practice

consumer. This price should fit the target audience’s
ability to pay. In an earlier study in Kenya, the authors
found out that nearly all university students interviewed were willing to pay for ECPs (Postinor 2) at an
estimated price of $1 (40 Kenya shillings at the 1996
exchange rate) rather than risk paying for abortion
services, which cost over a hundred times more. The
price for inducing an abortion was then estimated at
($100 or 4,000 Kenya shillings at the 1996 exchange
rate).25 Although ECPs are provided free of charge
in public-sector facilities, the findings showed that
availability of ECPs in private-sector outlets could be
sustained through direct sales of the pills to clients.

Placement. Where the product (or service) is available. Placement should factor in the type of outlet
(e.g., clinic, store, pharmacy) but also the operating
hours of such outlets. Given that some of the private
sector pharmacies in Kenya operate for 24 hours
especially in urban areas, clients seeking to buy these
commodities can theoretically access the services any
time, compared to the restrictions found in the public
sector regarding opening and closing hours and the
unavailability of these services during weekends and
public holidays (unless in the case of survivors of rape
or gender-based violence).
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Promotion. What advertising and communication

• EC does not protect against HIV or STI infection, and
• EC should be used only as an emergency method
and not as a regular form of contraception
Other sustainability factors critical to ensuring the
program’s success are:

The degree to which the principal target groups are
knowledgeable and motivated to utilize EC services
and their benefits improves sustainability. Low knowledge, poor motivation, and non-use of services are a
threat to sustainability.

Service quality
The degree to which high-quality services can continue
to be provided in the future is an indicator of program
sustainability. Low quality or the absence of key services can be a threat, while high quality may increase
demand for services and support.

Management support
Management support for activities such as planning
and supervision enhances the chance of sustaining
programs. Weak or missing support services can be a
threat to sustainability.

Policymakers’ commitments
High, broad-based commitment by policymakers is
conducive to sustainability; low, narrow-based com-

mitment is a threat. A commitment by policymakers
ensures the availability of the desired commodity and
facilitates in-country registration allocation of resources for procurement, distribution, monitoring, and
supervision activities. Policy commitment also builds
effective partnerships and facilitates the development
of appropriate standards, guidelines, and implementation of appropriate quality assurance activities.
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Policy Brief

Introduction

E

mergency contraception (EC) is an important element of reproductive health care. EC is the
only family planning method that can be used to prevent pregnancy after rape or unprotected sex. It does not cause abortion or harm to an existing pregnancy.

According to the 2003 Kenya Demographic Health Survey
(KDHS), close to half of the births in the preceding 5 years
were mistimed or unwanted. The preliminary results of the
2008 KDHS indicate that less than half (46%) of currently
married women were using some method of contraception;
use was lowest among women between the ages of 15 and
24. Increased access to family planning, including EC, can
reduce the number of unplanned pregnancies in the country
and contribute to lower rates of abortion, child neglect, and
abandonment.

“I think we have not adequately explained to the
community that the morning-after pill should be used
only in situations where
people have accidentally
had unprotected sex or in the
case of sexual coercion.”
- Dr. Shahnaaz Sharif, Director, Public Health and Sanitation, MOPHS

Despite increased media attention, EC remains a highly underutilized method across Kenya. Recent data indicate that
only 56% of women of reproductive age had ever heard of EC.1 To improve access to the method
and ensure that adequate information is provided to all users, the Ministry of Public Health and
Sanitation (MOPHS), the Population Council, and Population Services International- Kenya (PSI)
undertook a three-year effort to mainstream EC in Kenya, which was supported by the William
and Flora Hewlett Foundation. This brief presents the results of this initiative, and discusses strategies for further strengthening EC provision in Kenya.

What Is EC?
“Emergency contraception” refers to the use of certain contraceptive
methods by women and girls to prevent pregnancy after unprotected
sexual intercourse. These methods include specific dedicated products
(such as the brands Postinor 2 and Pregnon) and higher doses of other
hormonal birth control pills (known as the Yuzpe method). EC is recommended for women who have had unprotected sexual intercourse and
desire to prevent pregnancy. In Kenya, dedicated EC pills (ECPs), are
available in the public family planning clinics and as part of post-rape
care services; they are also widely found in Kenya’s private sector pharmacies and clinics.
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The Kenyan National Family Planning Guidelines recommend use of
ECPs within 120 hours for women who have had unprotected sexual
intercourse and desire to prevent pregnancy.2 EC is the only contraceptive method that provides women with a second chance for preventing
pregnancy after unprotected sex. ECPs do not cause abortion or harm an
existing pregnancy, and are widely recognized as safe and easy to use.
Any woman of reproductive age can use ECPs. While most women do not
experience side effects, the most common side effects, including nausea,
vomiting, and headaches, usually disappear within 24 hours. ECPs work
by either inhibiting or delaying ovulation or preventing fertilization, depending on the time it is taken during the cycle. Dedicated ECPs are effective in preventing up to 95% of pregnancies, and the Yuzpe method is effective in approximately
75–80% of cases; the efficacy of ECPs is greater if taken as soon as possible after unprotected sex.
Visit the following websites for more information on EC:

 ECafrique: The African Forum on Emergency Contraception; www.ecafrique.org
 The International Consortium on Emergency Contraception; www.emergencycontraception.org
 Not-2-late.com http://ec.princeton.edu/
 The Latin American Consortium on Emergency Contraception (in Spanish); www.clae.info

The initiative to mainstream ECPs in Kenya
In 2006, the Population Council and PSI launched an initiative to support the MOPHS’ efforts
to strengthen ECP provision in the public and private sectors. Activities included a national
awareness-raising campaign, technical assistance to the Division of Reproductive Health (DRH)
to build capacity and ensure supply sustainability, and efforts to improve ECP services in private
sector pharmacies.
Awareness-raising campaign: A national mass-media campaign, branded
Tulia (“relax” in Kiswahili) was undertaken to increase public awareness
of ECPs. It included national and local-language radio spots, informational articles in print media, expert interviews on radio and TV, and EC
messages presented through popular local soap operas. PSI also developed brochures answering clients’ key questions and concerns regarding
ECP use, which were distributed through pharmacies and private clinics.
To encourage bridging clients from ECPs to regular family planning
methods, PSI organized community-level events, such as discussion
groups and career fairs, that provided women aged 18–30 with information on ECPs and other regular family planning methods. All Tulia
materials contained contact information for a youth reproductive health
(RH) hotline run by Liverpool VCT, Care and Treatment. All hotline staff were trained to provide
information and counseling to women with questions about EC.
Public sector capacity-building: A study carried out by the Population
Council in 2007 found that, while 96% of FP providers had heard of EC,
only 56% had ever been trained to provide ECPs and far fewer demonstrated adequate knowledge of the method. Guided by these findings,
the DRH increased efforts to train FP providers on ECPs through contraceptive technology updates. Partners from the USAID-funded national
AIDS, Population and Health Integrated Assistance (APHIA II) Project,
which reaches providers across the country, were also encouraged to emphasize the method in their trainings. Through these efforts, over 2,000
providers received in-service training on ECPs between 2007 and 2008. A
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quick reference guide and job aid were also developed for providers, and the 2010 revision of the
National Family Planning Guidelines includes significantly strengthened guidance on ECPs.
The government also took steps to strengthen pre-service training as a sustainable and costeffective approach to improving provider competence. With technical assistance from the Population Council, the Nursing Council of Kenya revised its syllabus to include training on ECPs for
student nurses. Efforts are currently underway to integrate EC into the Kenya Medical Training
College’s curriculum.
Supply sustainability: To improve recordkeeping and allow facilities to re-order ECPs, in 2008 the
DRH added a column for ECPs to the revised FP register. The MOPHS also included purchase of
ECPs in its budget, and in 2009, procured 5,875,000 ECPs with its own funding.
Strengthened pharmacy services: The Population Council worked in collaboration with the Pharmaceutical Society of Kenya to address concerns of private providers regarding EC provision, and
test strategies for improving ECP services in the pharmacies. The Council conducted an intervention study which worked to enhance the
capacity of private pharmacy providers
to provide quality ECP services. The
study was conducted in 20 Nairobi pharmacies and included three components:
detailing providers on the appropriate
use of ECPs and how best to dispense
ECP to clients, ensuring the availability
of Tulia brochures and posters in participating pharmacies, and providing “cheat
sheets” containing five simple messages
on ECPs to display at the counter. The intervention also aimed to limit repeat use
by “bridging” current users to other RH
services, including VCT and longer-term “Cheat” sheets with the key messages on EC (English and
Kiswahili versions)
FP.

Lessons learned on ECP provision in Kenya
The initiative has helped improve understanding of the dynamics of ECP provision in Kenya,
increased access to the method in the public and private sectors, and developed innovative and
cost-effective strategies for providing basic information to users. The key lessons learned are
summarized below.

Awareness and use of ECPs has increased dramatically in Kenya, but still remains low
Awareness and reported use of ECP increased
dramatically over the life of the initiative. In
2003, the KDHS indicated that less than one
quarter of Kenyan women had ever heard of
ECPs.3 In 2007, PSI conducted baseline research in 13 major towns and peri-urban areas
across seven provinces, and found similar
patterns, with only 21% of women reporting
having ever heard of ECPs. Of those, only 15%
could correctly identify ECPs as a contraceptive method taken after sex to prevent preg-

Source

Year

Ever heard of
EC (women)

Ever
use

DHS

2003

24%

0.9%

PSI baseline (n=675)

2007

24%

5%

PSI endline (n=1252)

2009

56% *

10%*

* p=<0.05, comparing 2007 to 2009 results

Table 1: Knowledge and use of EC in Kenya, DHS
and PSI baseline surveys
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nancy.4 By 2009, 56% of women in the same sites had ever heard of ECP and 10% had ever used
the method.5
ECP sales data, obtained from the major ECP
distributors in Kenya, also demonstrate an
increased demand for the method. Figure 1
charts the dramatic growth in ECP sales by distributors over a 22-month period. During that
time, the number of ECP brands on the market increased from 3 to 4, indicating a robust
demand for the method. Similar trends are seen
in the public sector, although the volumes are
significantly lower.6
However, PSI’s end line survey indicates that
44% of all eligible women are still not aware
that ECP exists, and misconceptions are rife
Figure 1: National sales of 4 ECP brands, over
among those who do know about the method.
project life
Of all women who know of ECPs, one-third believe that it causes abortion, and only about two-thirds know the correct timeframe for using the
method. This indicates the need for continued education and awareness-creation on ECPs.

Private sector pharmacies dominate ECP provision in Kenya
Data collected under the initiative demonstrate that private sector pharmacies are the most common
access point for ECPs. PSI’s 2007 baseline survey found that 94% of women who had used ECP in
the past two years obtained it from pharmacies.7 In 2009, their endline survey found that while 83%
identified pharmacies as a place to obtain ECPs, only 25% mentioned government clinics.8
In 2008, as indicated in Figure 2, nationallevel ECP distribution through private
sector pharmacies was approximately twice
that distributed through the public sector.
Within government clinics, a 2007 record
review found that 93% of the ECPs distributed in the previous 18 months were for
sexual assault cases. While efforts under
this initiative worked to strengthen ECP
provision within FP and ARH services, it
is likely that a bias toward sexual assault
provision still exists within many public
health facilities.9

Figure 2: National sales of ECPs vs. public sector issues, 2008

Qualitative research conducted with ECP users indicated that they preferred to access ECPs
through pharmacies because it was convenient, quick and confidential.10 Two-thirds of women
who purchased ECPs indicated that they had visited more than one pharmacy in an effort to
maintain anonymity.11
These findings suggest that the challenge in delivering quality ECP services within pharmacies
lies with balancing efforts to provide basic information on the method without compromising
the qualities that make pharmacies so attractive to clients. Within the public sector, the challenge
rests with increasing the speed and confidentiality of ECP services within the context of larger FP
programs.
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The majority of women who purchase ECPs from pharmacies are educated and employed
Media reports have characterized ECP users, especially those who access EC from pharmacies, as
“girls as young as 14.”12 Research conducted under this initiative, however, indicates that this is
not the case. In 2007, the Population Council conducted a client intercept study (where clients are
interviewed after receiving a service) with 147 women who bought ECPs at pharmacies in urban
pharmacies located in five provinces (Nairobi, Coast, Rift Valley, Nyanza, and Western).
The results show that the average age of women surveyed was 25 years, and the majority were
between 20–29 years (72%). None of these women reported that they were aged 14 or below, and
only 11% of respondents were between the ages of 15–19. Most clients had a college/university
level of education (61%) and 61% were currently employed (including self-employment). About
two-thirds (65%) were either married/cohabiting or single but in a steady relationship, but most
women (57%) also reported engaging in sex on an infrequent or irregular basis. A significant proportion (41%) reported having at least one child.13

Some Kenyan women have used ECPs more than once in a month, but repeat users are less
informed about the method
Respondents in the 2007 client intercept study were asked about the number of times they had
used ECPs in the past six months, frequency of use in relation to sexual activity, and time since
last purchase of ECPs. The categorization of “repeat use” is based on the last question, and is
defined as a client who has bought ECPs at least once previously in the past one month.
Data indicate that a majority (58%) of women who had purchased ECPs had done so two or more
times in the last month. Most of these purchasers (74%) stated that they used ECPs as their only
method during their last act of sex, and nearly as many (70%) thought that ECPs were more convenient than other methods, while almost half preferred ECPs over methods such as daily contraceptive pills or injectables.
While repeat use of ECPs may be a conscious decision, it is not necessarily an informed one. The
data also demonstrate that women who repeatedly used ECPs had greater misperceptions about
the method’s mechanism of action and efficacy. Nearly 60 percent believed that ECPs are 100% effective, and many incorrectly believed that it would cause infertility or abortion. Overconfidence
in ECP’s efficacy is likely to be one factor underpinning repeat use, with the benefits of convenience in the short-term outweighing perceived long-term consequences.14
It is important to note that no significant negative health consequences have been associated with
repeat use of ECP.15 Current national and international guidelines, however, do not encourage
reliance on EC as a regular method of FP. According to the World Health Organization, recurrent
use of EC indicates the need for further counseling on contraceptive options.16 No conclusive evidence is available on the efficacy of ECPs if taken more than once in a cycle.

Pharmacies can provide better ECP services with minimal investment
Given the key role pharmacies currently occupy in the provision of ECP in Kenya, and the demonstrated need for better client counseling, innovative efforts are needed to improve EC services
within pharmacies.
The strategy for providing basic information to pharmacy clients tested under this initiative demonstrated promising results. Results of this intervention indicated that, when given basic information, pharmacy staff were more likely to provide basic information on ECPs (including when and
how to use, mechanism of action, side effects, and efficacy) and discuss other FP and RH services
with clients. These results suggest that sales staff at private sector pharmacies can deliver better
ECP services, if given the proper tools. It also indicates that extensive, and often costly, training
efforts are not needed to improve services within pharmacies.17
27

Integrating skills and knowledge on ECPs into existing pre-service and in-service training
programs can enhance public sector provision
Under the initiative, efforts focused on integrating EC into existing pre- and in-service training
programs in a cost-effective and sustainable manner. With minimal resources, modules on ECPs
were inserted into ongoing trainings conducted by APHIA II partners and in the regular MOPHS
Contraceptive Technology Updates (CTUs); evaluation data showed increased knowledge among
trained providers. Perhaps the most strategic investment was in pre-service training, where limited technical and financial support enabled the integration of EC into the revised Nursing Council’s curriculum, ensuring that all future nurses will receive instruction on ECPs.
These experiences demonstrate that existing FP and RH initiatives can be successfully used to
promote knowledge on ECPs. They also underscore the utility of integrating EC into existing
activities, which is more-cost effective than stand-alone trainings and promotes the principle that
EC should be addressed in the context of comprehensive FP and post-rape care services.

Active advocacy is necessary to ensure adequate ECP stocks in the public sector.
Supply sustainability of all contraceptives, especially ECPs, remains a major challenge for the
Kenyan government. Continued or sustained stock-outs would undermine the gains made during this initiative, and limit the impact of the policy and program changes that have been undertaken in recent years. As knowledge of ECPs increase throughout the country, so will supply
requirements, and efforts to ensure sufficient commodities should continue.
Under the leadership of the DRH, advocacy efforts ensured that ECPs were included in the national contraceptive security plan and subsequent procurements. Since 2005, UNFPA has donated
approximately 1,100,000 units to the MOPHS. In 2009, the MOPHS committed its own funds to
purchase the country’s largest procurement of ECPs to date of 5,875,000 units.

Recommendations
The following recommendations are based on the lessons learned under this initiative.
1. Efforts to create public awareness and correct knowledge of ECPs should be continued. While
knowledge of ECPs is increasing in Kenya, many potential beneficiaries are still unaware of
the method and many others are misinformed. Accurate public information and education is
critical for encouraging correct use of ECPs. It is important, therefore, to include messages on
ECPs in comprehensive FP communication campaigns. This can be achieved by integrating
the existing Tulia materials and messages into the national RH communication strategy operational plan, and in the DRH’s community education and communication activities. The media
can also play a critical role in creating correct public perceptions of the method, and should be
regarded as a partner in these activities.
2. Professional associations, including the Pharmaceutical Society of Kenya and the Kenya
Pharmaceutical Association, should continue educating their members on proper ECP provision. Given the central role pharmacies play in ECP access in Kenya, professional associations
should work to confirm that their members are aware of strategies for ensuring clients are
provided with the information they need to make informed decisions on ECP use. Such strategies need not be costly or time-intensive; this initiative demonstrated one model for increasing information provision in pharmacies, and others are likely to be feasible. At a minimum,
the professional associations should include informational sessions and discussions on ECPs
at all general meetings.
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3. All MOPHS training partners should ensure that ECPs are integrated into all trainings on
FP, RH, adolescent health, or post-rape care. Numerous local and international NGOs assist
the MOPHS with provider training. These partners’ contributions can also be used to increase
knowledge on ECPs, with as little as two additional hours of instruction for trained health
care providers. The DRH should integrate existing training materials and job aids into a
standardized module on ECPs to ensure that all partners offer uniform, high-quality instruction.
4. All pre-service training institutions and bodies should include ECP provision in their curricula and examinations. Pre-service training is necessary to ensure that the next generation
of Kenya’s health professionals are well equipped to provide this important and increasingly
popular method. To do this, the country’s leading medical pre-service training institutions
must revise their curricula to reflect the MOPHS’ renewed emphasis on quality ECP provision.
5. The MOPHS, donors, and partners should continue to ensure that adequate ECP supplies are
available in the public sector. Adequate stocks are essential in ensuring the success of public
sector ECP provision. Remarkable progress toward this has been achieved through the inclusion of ECP in the government’s FP commodities procurement and security plans. It is recommended that donors and other MOPHS partners continue to support the government to ensure that this emphasis on stock sustainability is maintained. Donors can also encourage their
partners to integrate ECP issues in their reproductive health communications, service delivery, logistics, trainings, and research programs, and to explore innovative ways to strengthen
private sector provision.

Conclusion
Kenya has emerged as a leader in EC programming in the region. Through this initiative, it has
demonstrated that it is possible to strengthen ECP services in both the public and private sectors
while at the same time increasing public awareness, knowledge, and use of the method.
The Kenyan experience can serve as a model for other countries on the continent interested in
mainstreaming ECP services. While Kenya may have a longer history with the method than other
African countries, ECPs are rapidly becoming widely available in African pharmacies due to the
aggressive expansion of new products. Countries such as Uganda, Botswana, Ghana, Nigeria,
Malawi, and Senegal are beginning to grapple with increased access in the private sectors, while
many other governments are now more widely providing ECPs as a core element of post-rape
care. The lessons learned from Kenya can serve as an invaluable resource to these countries.
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Emergency Contraception
Health Care Providers Quick Reference Guide
Introduction

According to the Kenya Demographic
and Health Survey of 2003, close to
half of the births in the preceding five
years were mistimed or unwanted.
Unplanned pregnancies lead women
to seek abortions or have children
they do not care for effectively. Use
of emergency contraceptives (EC) is
recommended for women who have
had unprotected sexual intercourse and
want to prevent pregnancy. The Ministry of Health recommends use of emergency contraceptives (EC) within 120
hours for women who have had unprotected sexual
intercourse and want to prevent pregnancy. Effective provision of EC is an important component of
adolescent reproductive health and post-rape care
programs.
“I think we have not adequately explained to the
community that the morning-after pill should be
used only in situations where people have accidentally had unprotected sex or in the case of sexual
coercion.” (Dr. Shahnaaz Sharif, Head of Technical
Services, Ministry of Public Health & Sanitation.
Remarks made at the World Contraception Day
event at Kangemi, Nairobi on 26 September 2008.)
“We need to educate members of the public so that
they have the correct information regarding the use
of the morning-after pill.” (Rosalyn Gichora, District
Officer, Nairobi West District. Remarks made at
the World Contraception Day event at Kangemi,
Nairobi on 26 September 2008)

Why This Guide?

prevent pregnancy after unprotected
sexual intercourse. These methods
include specific products like Postinor 2, and normal birth control pills.
They should not be used as routine
methods of family planning (FP).

Why Is EC Important?

• EC provides a second chance for
preventing pregnancy after unprotected sex.
• EC can reduce unwanted pregnancy which may result in child neglect, abandonment, and unsafe abortions. Unsafe abortion
is a major cause of maternal death in Kenya.
• EC is an important element in adolescent reproductive health programs. Young people need to
have correct information on many of the risk factors that are likely to negatively impact their lives
such as sexually transmitted infections (STIs)
HIV/AIDS and unintended pregnancies.
• EC is important for post-rape care, prevention
of mother to child transmission of HIV, and is an
essential component of quality FP service provision.

When Does a Woman Need to Use
EC?

EC is used after unprotected sex, including in the
following situations:
• When no FP method is used.

The Health Care Providers Quick Reference Guide
has been developed as part of a larger ongoing
program on mainstreaming EC in the public and
private sectors. The main objective of this guide is
to give an opportunity to health care providers to be
able to make quick reference on any key issue with
regard to EC in the course of their work. It is intended to supplement the information on EC provided
in the current MOH Family Planning Guidelines for
Service Providers.

• When a method is used but it does not function
properl,y e.g., condom breaks, IUD slips out.

What Is EC?

Key Points about EC Pills

Emergency contraception refers to the use of certain contraceptive methods by women and girls to
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• When a woman forgets to take oral contraceptive
pills for two or more days, or delays injectable for
more than two weeks
• When a woman is raped/coerced into unprotected
sex.

• Safe, effective, and easy to use. EC can be used
safely by adolescents.

• Should be started as soon as possible, but within
120 hours of unprotected sex. The second pill
should be taken within 12 hours after the first or
alternatively the two pills can be taken at once (as
a single dose).
• Referred to as “morning-after pill”, but this reference is misleading as it implies that one has to
wait for some time before using the pill.
• No medical exam or pregnancy tests necessary.
• Can be used any time of the menstrual cycle.
• Should not be used as a regular method of contraception because EC pills are less effective and
have more side effects than other family planning
methods.
• EC pills do not work once a woman is pregnant.
Therefore women/girls who are already pregnant
should not take EC pills. However they will not
harm a fetus that is already formed or cause a
miscarriage.
• EC pills are available in MOH facilities and over
the counter at pharmacies.

How Does EC Prevent Pregnancy?

EC pills work in various ways depending on the
time in a woman’s cycle when she has sexual
intercourse. EC does not cause abortion because it
works before implantation.
EC Pills are thought to:
• Inhibit or delay ovulation.
• Inhibit/slow down transportation of egg/sperm
through the fallopian tubes, hence preventing
fertilization.
• Prevent implantation.

Types of Hormonal EC Pills/
Characteristics of EC Pills

1. Dedicated EC pills contain the same progestin
hormones as other progestin-only pills, although
in higher doses. They are more effective than
combined oral contraceptive pills and cause
fewer side effects. This regimen prevents pregnancy by about 85% if taken within 120 hours.
• There are many brands of dedicated EC pills
currently available in Kenya, such as Postinor
2, Pregnon, Smart Lady, ECee2, and Truston2.
• Some of these brands are found in government
health facilities and should be ordered in the
same way as other contraceptives.

2. Combined oral contraceptive pills, also called
Yuzpe method, contain the hormones estrogen
and progestin and prevent about 75% of expected pregnancies.
3. Progestin-only contraceptive pills can be used for
EC. One needs two doses of 20 tablets.

The following are dosage guidelines
for different EC pills regimens
Common
brand
names

Tablets
per
dose

Dedicated EC pillLNG ECP package
with single dosage
pill of 1.5mg of
levonorgestrel **

Postinor 2
Pregnon
Smart lady
Ecee2

1
1
1
1

1
1
1

Dose to be
taken within
120 hours after
unprotected
sex.

Dedicated EC pillsLNG ECP package
containing two pills
of 0.75 mg of levonorgestrel each**

Postinor 2
Pregnon
Smart lady
Ecee2

2
2
2
2

1
1
1
1

Dose to be
taken within
120 hours after
unprotected
sex.

50 mcg estrogen
pills

Eugynon

2

2

30 mcg estrogen
pills

Microgynon

4

2

Progestin only pills

Microlut

20

2

First dose to be
taken within 120
hours after unprotected sex.
Second dose 12
hours later.

Pill type

Doses

Timing of
administration

**1.5 mg of levonorgestrel or two 0.75 mg of levonorgestrel pills taken at once
in a single dose improves compliance (1.Dada OA, Godfrey EM, Piaggio G, von
Hertzen H. “A randomized, double-blind, noninferiority study to compare two
regimens of levonorgestrel for emergency contraception in Nigeria.” Contraception
2010; 82(4): 373-8. 2. Piaggio G, Kapp N, von Hertzen H. “Effect on pregnancy
rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials.” Contraception 2011; 84 (1): 35-9).

Side Effects and Management

• Nausea and vomiting are the most common side
effects.
• Other possible effects include headaches, dizziness, fatigue, and breast tenderness due to the
high hormone doses in emergency contraception
pills.
• Most side effects generally disappear within 24
hours of taking the pills.
• To reduce the effects of nausea, EC pills can be
taken with food or a medical provider can offer
anti-nausea drugs before taking EC.
• If a woman vomits <2 hours after taking a dose of
EC the dose should be repeated.
• If vomiting occurs more than 2 hours after taking
ECPs, she does not need to take any extra pills.
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Counseling Clients

Women needing EC may be in crisis and fear
unplanned pregnancy. As much as possible it is
important for a provider to counsel a client on EC.
Unless in the case of rape, it is an opportunity to
discuss use of regular FP method.
• Recommend that the client use a method of FP
for the rest of the cycle after taking EC pills.
• Many women who need EC also need protection
from STIs/HIV. Counseling on EC is an opportunity to discuss the risks of STIs and prevention
options.
• When you explain mode of action to clients, reassure them that EC pills do not cause abortion.
• Discuss the possibility that EC may fail.
• Refer clients for FP and other reproductive health
services. Women who have been raped or traumatized need to be referred for more comprehensive medical and psychosocial care.

Starting Family Planning Methods
after EC
Method
Condom

When to start
Immediately after EC
Use also for dual protection

Oral contraceptive pills

Next day after 2nd dose of EC
or 1–7 days after menses

Injection
IUD
Norplant

1–7 days after next period

EC pills and HIV/AIDs/STIs

EC pills do not protect against STIs including HIV.

• All EC users should also be referred for voluntary
counseling and testing.

• In case of rape, providers can give post-exposure
prophylaxis for STIs/HIV.

Common questions
• What are the effects of EC on periods?

EC pills do not cause periods to start immediately.
Periods will come at the normal time but may be
delayed or come early by 2–3 days.

• Can EC pills protect one for the rest of the cycle?
It will not, and any further unprotected acts put
one at risk. Women should use a regular method
of FP or condoms for further protection.

• Can EC pills harm an already formed baby?

No. It has been determined that EC pills do not
have any serious harmful effects ona formed
baby.

• When can one resume/start a regular FP method
after taking EC?
One can start by using condoms and pills. One
has to wait until the next period to begin using
injections, IUDs and implants.

• Can I use EC pills every time I have sex?

Women/girls should not use EC pills as a regular
method. They should only be used in emergency
situations. EC pills are less effective than many
regular FP methods.

• What if I have unprotected sex again after taking
EC?

If one has unprotected sex after using EC, it will
not offer protection from pregnancy. One will need
to repeat the treatment, unless already using a
regular FP method.

• What if I had sex multiple times before taking EC
pills?
You can still use EC pills if the last time you had
sex was within five days. If one is already pregnant from an earlier act of unprotected sex, the
EC pills will not have any effect.

This booklet has been adapted from the National FP Guidelines (Kenya MOH, 2005), with additional
information drawn from Family Planning: A Global Handbook for Providers (WHO: Geneva, 2008). The
adaptation was conducted by the staff of the Division of Reproductive Health, Ministry of Public Health and
Sanitation and ECafrique staff of the Population Council. Publication date 2008.
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H.3
Selling
Protocol for
Emergency
Contraception
Pills
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Below is a recommended emergency contraceptive pills (ECPs) selling protocol that the Population
Council in collaboration with other professionals
proposes can be used in dispensing the emergency
pills.

1. Assess the risk of pregnancy:
• In case of missed pills: Advise the patient to
carry on with the next pill as normal. If they had
unprotected sex, then emergency contraceptive pills are indicated. Inform the patient that
they will not be covered by the contraceptive
and that a barrier form of contraception such
as a condom should be used for a further 10
days or until the end of the cycle. They can
have their normal break and carry on with the
regular contraception as normal.
• In case of a broken, slipped condom, the emergency contraceptive pills (ECPs) are indicated
and should be administered as soon as possible.
• In case of unprotected sex including both consensual and nonconsensual sex: EC pills are
indicated and should be administered as soon
as possible.

2. Establish if the client is taking any other
medication.
Many enzyme-inducing drugs reduce the effectiveness of emergency pills. Drugs to watch out
for are anticonvulsants such as carbamezapine,
and phenytoin; anti-HIV drugs such as ritonavir;
anti-TB drugs such as Rifampicin and Rifambutin; herbal drugs; cyclosporin; and antibiotics.

3. Establish if the client has any stomach condition such as Crohn’s or severe liver disease.
These can reduce the absorption and metabolism of ECPs.
4. Ensure that the client is within the 120-hour
period.
5. Give advice:
a. EC Pills: two tablets can be taken at the
SAME time, avoiding the need to wait for 12
hours, with the same efficacy.
b. Take the pills as soon as possible.
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c. The pills may induce nausea; however, if the
client vomits within three hours of taking the
pill, she should return and purchase another
dose as the first dose may not work.
d. Side effects are rare and transient. Side effects may be headaches, dizziness, breast
tenderness, nausea, and vomiting. If the
client is concerned, she should speak to her
doctor; however, after years of research on
this drug, there is no evidence of any longacting adverse effects.
e. Advise the client that her next period may be
heavy or light, early or late. If it is more than
five days late she should seek medical advice
and get herself tested for pregnancy.
f. Advise clients on the use of regular contraception and risks of STIs.

6. EC reference materials should be given out.
These include the EC Quick Reference Guide
and the 2010 edition of the National Family
Planning Guidelines by the Division of Reproductive Health (DRH) of Kenya’s Ministries of
Health for providers; and guides such as the
Tulia patient information brochure developed by
MOHs and partners for patients. The patient information guides should be given out to complement the advice given.
7. Communication: Communicate with empathy,
discretion, and in a nonjudgmental way. Ask
open questions and double-check the patient’s
understanding. If you can, have a quiet area in
your pharmacy where private discussions can
be held.
Some pharmacists and health care professionals
have expressed concerns that women might “abuse”
emergency contraception pills by using them repeatedly or using them instead of regular contraception.
The main point to bear in mind here is that from a
safety point of view, no serious side effects have been
reported from repeated use of levonorgestrel ECPs,
usually a change in the menstrual cycle is seen. If advice is given on regular contraception and the risk of
STIs including HIV/AIDS at the point of supply of ECPs,
then pharmacists will also be playing a major role in
the effective use of emergency contraception and
family planning in general. It is in the pharmacists’
hands to uplift the profession. The sale and supply of
ECPs enables pharmacists to play a more active role
in improving the sexual health of the nation.

H.4
Job Aid for
Bridging
EC Users
to Other
RH Services
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Source: MOH-Kenya. 2010. National Family Planning Guidelines for Services Providers.
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Hormonal
Emergency
Contraception
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Hormonal Emergency Contraception: What Is It?
Emergency contraception refers to the use of certain contraceptive methods by women in the reproductive age group to prevent pregnancy after unprotected sexual intercourse. Hormonal emergency contraceptive pills (ECPs) must be taken within 120 hours of intercourse, however, the sooner they are taken,
the more effective they are. EC provides a second chance for preventing pregnancy after unprotected
sex, either accidental or following coerced sex/rape.
It should be emphasised that emergency contraception should not be used on a regular basis
(from month to month) because it is less effective than other methods.
Depending on the regimen used and number of hours passed since unprotected intercourse, emergency contraceptive pills seem to prevent between 75% and 95% of pregnancies that would otherwise
have occurred. The average chance of pregnancy resulting from one act of unprotected intercourse in
the second or third week of the menstrual cycle is estimated at 8%; after emergency oral contraception
it is 1–2%. The sooner after unprotected intercourse ECPs are used, the more effective they are in preventing pregnancy. Also a progestin-only regimen is more effective than a combined oral contraceptives
regimen.
Emergency contraception pills work in various ways to prevent pregnancy. This depends on the time in
a woman’s cycle when she has sexual intercourse. EC does not cause abortion because it works before
implantation. Thus EC pills prevent pregnancy by:
•
•

Preventing or delaying ovulation; and
Inhibiting or slowing down transportation of the egg and/or sperm through the fallopian tubes;
hence preventing fertilization and implantation.

TYPES OF HORMONAL EC PILLS AND DOSAGE
Combined Oral Contraceptives (COC) (also called Yuzpe method).
These contain the hormones estrogen and progestin and prevent about 75% of the expected pregnancies.
50 mcg estrogen pills (e.g. , Eugynon): Two tablets to be taken as soon as possible, but within
120 hours of unprotected intercourse. Repeat same dose in 12 hours. A total of 4 pills are required.
Or

30 mcg estrogen pills (e.g., Microgynon): Four tablets to be taken as soon as possible, but
within 120 hours of unprotected intercourse. Repeat same dose in 12 hours. A total of 8 pills are
required.
Progestin-only Oral Contraceptives
Dedicated emergency contraceptive (levonogestrel) pills:
These contain the same progestin hormones as other progestin-only pills, although in higher doses.
They are more effective than combined pills. Examples of brands of dedicated EC pills available in
Kenya are: Postinor 2, Pregnon, Smart lady, ECee2, and Truston2, among others.
One 750 mcg levonorgestrel pill to be taken as soon as possible, but within 120 hours of unprotected intercourse. Repeat same dose in 12 hours. A total of 2 pills are required.
Or

Two 750 mcg levonorgestrel pills to be taken as a single dose as soon as possible, but within
120 hours of unprotected intercourse. This regimen is preferred because the issue of compliance with treatment does not arise.
Or

Regular progestin-only pill (POP) may be used: 20 tablets taken within 120 hours of unprotected intercourse. Repeat same dose in 12 hours. A total of 40 pills are required.
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Dosage guidelines for different EC regimens
Pill type

Common
brands

a) Combined oral contraceptive pills:
50 mcg estrogen pills

30 mcg estrogen pills

Eugynon

Microgynon

b) Progestin-only dedicated EC Pills:
750 mcg levonorgestrel pill

1.5 mg (1500mcg)
levonorgestrel pill*

Postinor 2,
Pregnon,
Smart lady,
Ecee2,
Truston2

Postinor 2,
Pregnon,
Smart lady,
Ecee2,
Truston2

c) Regular progestin only pill (POP)
Regular progestinonly pill (POP)

Microlut

Tablets
per dose

Doses

Total Timeframe for
doses administration of dosage

2

2

4

First dose within 120 hrs; 2nd
dose 12 hrs later

1
1
1
1
1

2
2
2
2
2

2

First dose within 120 hrs after
unprotected sex; 2nd dose 12
hrs later

4

4

8

2
2
2
2
2

1
1
1
1
1

2

Single dose within 120 hrs
after unprotected sex.

20

2

40

First dose within 120 hrs after
unprotected sex; 2nd dose 12
hrs later

* This regimen is preferred since it improves compliance (WHO 2008: Global Handbook for Providers on FP and
Emergency Contraception- Health Care Providers Quick reference Guide(MOPHS, DRH 2008).

ADVANTAGES
• Provides emergency protection (prevents pregnancy) in about 75% to 95% of those at risk.
• EC can reduce unwanted pregnancy which may result in child neglect, abandonment, or unsafe
abortions which are a major cause of maternal death in Kenya.
• Is an important element in post-rape care, prevention of mother-to-child transmission of HIV and is
an essential component of quality family planning service provision.
• Safe, effective, and easy to use.
• No medical examination or pregnancy tests are necessary or required.
• Can be used any time during the menstrual cycle.
• Emergency contraception pills are available in the government, private, and NGO health facilities
and over the counter at pharmacies.

LIMITATIONS
• Only effective within 120 hours of unprotected intercourse.
• Not to be used as a regular method.
• Does not protect against STls/HIV/AIDS.
• May cause nausea (more common for COC regimen).
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WHO CAN USE EMERGENCY CONTRACEPTION ?
Emergency oral contraception should not be used in place of regular family planning methods. It
should be emphasised that EC contains a much higher dose of the hormones compared to the regular
hormonal contraceptive methods. Therefore, it should be used only in an emergency, for example:
• Sex took place without contraception, and the woman wants to avoid pregnancy.
• A woman has run out of oral contraceptives, has missed 2 or more POPs, or is more than 4 weeks
late for her DMPA injection and has had unprotected intercourse.
• A woman has had coerced sexual intercourse, such as rape.
• A condom has broken.
• An IUD has come out of place.
Proceed with care in the following situations
CONDITION
SUGGESTED ACTION
Women with history of severe
cardiovascular complications (e.g.,
IHD, CVA or other thromboembolic
conditions)

Should be given the regimen without the delay; they may
need follow-up after they have taken the pills.

Woman with angina pectoris

Pregnancy poses much more risk for these women than
ECPs do.

Women suffering from migraine
Women with severe liver disease
(including jaundice)

Any delay may take them to the point beyond 120 hours
when ECPs are not effective anymore,

The duration of use of EC is less than that of regular use of
COCs or POPs and thus would be expected to have less
clinical impact.

WHO SHOULD NOT USE
EC is not to be used as a regular method. Recurrent demand for EC is an indication that the woman
requires further counseling on other contraceptive options.
Frequently repeated EC use may be harmful for women with conditions classified as “Use with care”
(category 2) and “Who should not use” (categories 3 and 4) for hormonal methods.
EC should not be given to women who are known to be pregnant.
The success of emergency contraception depends on awareness and knowledge of its availability/efficacy prior to an unprotected, unplanned act. The method is only effective if potential
users are aware of the method by prior information and counseling.

KEY POINTS FOR PROVIDERS AND CLIENTS
• EC pills should be started as soon as possible, but within 120 hours of unprotected sex
• EC is referred to as the “morning-after pill,” but this reference is misleading as it implies that one
has to wait for sometime before using the pill.
• Emergency contraception pills do not work once a woman is pregnant. Therefore women/girls who
are already pregnant should not take emergency contraception pills.
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Management of common side effects
SIDE EFFECTS

MANAGEMENT

Nausea and vomiting
(more common with
COC regimen)

Women should be counseled of the possible occurrence of nausea at the
time of ECP supply. For women using a combined pill or POP for ECP, where
possible, an anti-emetic may be used before the pills are taken.
If vomiting occurs within 2 hours, repeat the previous ECP dose orally as
soon as possible.
If a woman again vomits, give the dose vaginally (place the needed dose
high up in the vagina)

Slight irregular bleeding

Reassure that this is not a sign of pregnancy or other condition.
Irregular bleeding due to ECPs is common and will stop without treatment.

Change in timing of next
monthly bleeding

Explain that it is not unusual for the next monthly bleeding to start a few days
earlier or later than expected.
Assess for pregnancy if woman’s next monthly bleeding is more than one
week later than expected.

WHO CAN PROVIDE EC?
Clinical Providers
• Medical Doctors
• Nurses/Midwives
• Clinical officers
Non-clinical providers
• Trained Pharmacists/Pharmaceutical Technologists
• Trained Community Health Extension Workers (CHEWs)- Nurse/midwives, Public Health Officers
(PHO), Public Health Technicians (PHT)
• Trained Community Health Workers (CHWs) including Community–based Distributors (CBDs)
Other Providers
• All trained providers including CBDs, pharmacy assistants, community health workers, trained
peer counselors.1

WHERE EC CAN BE PROVIDED
All service delivery points:
• Level 4 and above (hospitals)
• Level 3 (health Centers, nursing/maternity homes)
• Level 2 (dispensaries, HTC centers, private clinics)
• Level 1 (outreach, including CHWs, CBDs, and mobile services), pharmacies/ chemists, SGBV
centers) and any site with a trained provider (home, shop).

1

World Health Organisation (2012), WHO recommendations. Optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting.
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STARTING FAMILY PLANNING METHODS AFTER EC
Method

When to start

Condom

Immediately after EC use also for dual protection

Oral contraceptive pills

Next day after 2nd dose of EC or 1–7 days after menses

Injection

1–7 days after next period

IUD
Norplant
Permanent method
Natural method

BRIDGING EC USERS TO OTHER REPRODUCTIVE HEALTH SERVICES
EC providers are expected to explain the mode of action of EC to the client including the fact that EC is
not 100% effective at reducing the risk of pregnancy. Except in the case of rape, providers are expected
to discuss the use of a regular FP method and emphasize that EC pills are for emergency use only. All
providers are supposed to inform users of all FP methods available and that the FP methods (except
condoms) do not protect women against sexually transmitted infections (STIs) including HIV/AIDS.
Many women who need EC also need protection from STIs/HIV and therefore counseling on EC is an
opportunity to discuss the risks and prevention options for STIs/HIV/AIDS including the need for counseling and testing services. Refer clients for FP and other RH services. Women who have been raped
or traumatized also need to be referred for more comprehensive medical and psychosocial care.

Common Questions
•

What are the effects of EC on periods? EC pills do not cause periods to start immediately.
They will come at the normal time but may delay or come early by 2–3 days

•

Can EC pills protect one for the rest of the cycle? They will not, and any further unprotected
acts put one at risk. Women should use a regular method of FP or condoms for further protection.

•

When can I resume/start a regular FP method after taking EC? One can start by using condoms and pills. One has to wait until next period to begin using injections, IUDs, and implants.

•

Can I use EC pills every time I have sex? Women/girls should not use EC pills as a regular
method. They should only be used in emergency situations. EC pills are less effective than many
regular FP methods

•

What if I had sex multiple times before taking EC pills? You can still use EC pills if the last
time you had sex was within 5 days. If one is already pregnant from an earlier act of unprotected
sex, the EC pills will not have any effect.

Source: MOH-Kenya. 2010. National Family Planning Guidelines for Services Providers.
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Emergency contraception
Fact sheet N°244
July 2012

Key facts
• Emergency contraception can prevent most pregnancies when taken after intercourse.
• Emergency contraception can be used following unprotected intercourse, contraceptive failure, incorrect
use of contraceptives, or in cases of sexual assault.
• There are two methods of emergency contraception: emergency contraceptive pills (ECPs) and copperbearing intrauterine devices (IUDs).
• When inserted within five days of unprotected intercourse, a copper-bearing IUD is the most effective
form of emergency contraception available.
• The emergency contraceptive pill regimen recommended by WHO is one dose of levonorgestrel 1.5 mg,
taken within five days (120 hours) of unprotected intercourse.
Emergency contraception, or post-coital contraception, refers to methods of contraception that can be
used to prevent pregnancy in the first few days after intercourse. It is intended for emergency use following
unprotected intercourse, contraceptive failure or misuse (such as forgotten pills or torn condoms), rape or
coerced sex.
Emergency contraception is effective only in the first few days following intercourse before the ovum is
released from the ovary and before the sperm fertilizes the ovum. Emergency contraceptive pills cannot
interrupt an established pregnancy or harm a developing embryo.
Who needs emergency contraception?
Any woman of reproductive age may need emergency contraception at some point to avoid an unwanted
pregnancy.
In what situations should emergency contraception be used?
Emergency contraception can be used in a number of situations following sexual intercourse:
• When no contraceptive has been used.
• When there is a contraceptive failure or incorrect use, including:
• condom breakage, slippage, or incorrect use;
• three or more consecutively missed combined oral contraceptive pills;
• the progestogen-only pill (minipill) taken more than three hours late (or more than 12 hours late if taking a 0.75 mg desogestrel-containing pill);
• norethisterone enanthate (NET-EN) progestogen-only injection taken more than two weeks late;
• depot-medroxyprogesterone acetate (DMPA) progestogen-only injection taken more than four weeks
late;
• the combined estrogen-plus-progestogen monthly injection taken more than seven days late;
• dislodgment, delay in placing, or early removal of a contraceptive hormonal ring or skin patch;
• dislodgment, breakage, tearing, or early removal of a diaphragm or cervical cap;
• failed withdrawal (e.g., ejaculation in the vagina or on external genitalia);
• failure of a spermicide tablet or film to melt before intercourse;
• miscalculation of the periodic abstinence method, or failure to abstain or use a barrier method on the
fertile days of the cycle;
• expulsion of an intrauterine contraceptive device (IUD) or hormonal contraceptive implant.
• In cases of sexual assault when the woman was not protected by an effective contraceptive method.
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Methods of emergency contraception
There are two methods of emergency contraception:
1. emergency contraception pills (ECPs)
2. copper-bearing intrauterine devices (IUDs).
1. Emergency contraception pills
WHO recommends levonorgestrel for emergency contraceptive pill use. Ideally, this progestogen-only
method should be taken as a single dose (1.5 mg) within five days (120 hours) of unprotected intercourse.
Alternatively, a woman can take the levonorgestrel in two doses (0.75 mg each; 12 hours apart).
Mode of action
Levonorgestrel emergency contraceptive pills prevent pregnancy by preventing or delaying ovulation. They
may also work to prevent fertilization of an egg by affecting the cervical mucus or the ability of sperm to
bind to the egg.
Levonorgestrel emergency contraceptive pills are not effective once the process of implantation has begun,
and they will not cause abortion.
Effectiveness
Based on reports from nine studies including 10,500 women, the WHO-recommended levonorgestrel regimen is 52–94% effective in preventing pregnancy. The regimen is more effective the sooner after intercourse it is taken.
Safety
Levonorgestrel-alone emergency contraception pills are very safe and do not cause abortion or harm future
fertility. Side effects are uncommon and generally mild.
Medical eligibility criteria and contraindications
Emergency contraceptive pills prevent pregnancy. They should not be given to a woman who already has
a confirmed pregnancy. However, if a woman inadvertently takes the pills after she becomes pregnant, the
available evidence suggests that the pills will not harm either the mother or her fetus.
Emergency contraceptive pills are for emergency use only and are not appropriate for regular use as an
ongoing contraceptive method because of the higher possibility of failure compared with non-emergency
contraceptives. In addition, frequent use of emergency contraception can result in side effects such as
menstrual irregularities, although their repeated use poses no known health risks.
There are no medical contraindications to the use of levonorgestrel emergency contraception pills.
2. Copper-bearing intrauterine devices (IUDs)
WHO recommends that a copper-bearing IUD, as an emergency contraceptive, be inserted within five days
of unprotected intercourse. This may be an ideal emergency contraceptive for a woman who is hoping for
an ongoing, highly effective contraceptive method.
Mode of action
As emergency contraception, the copper-bearing IUD primarily prevents fertilization by causing a chemical
change that damages sperm and egg before they can meet.
Effectiveness
When inserted within five days of unprotected intercourse, a copper-bearing IUD is over 99% effective in
preventing pregnancy. This is the most effective form of emergency contraception available. Once inserted,
the woman can continue to use the IUD as an ongoing method of contraception, and she may choose to
change to another contraceptive method in the future.
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Safety
A copper-bearing IUD is a very safe form of emergency contraception. The risks of infection, expulsion or
perforation are low.
Medical eligibility criteria and contraindications
The only situation in which a copper-bearing IUD should never be used as emergency contraception is if
a woman is already pregnant. There are other contraindications to using a copper-bearing IUD as ongoing contraception, which also should be considered before its use as emergency contraception. For more
information, please refer to the WHO Medical Eligibility Criteria for Contraceptive Use.
WHO response
WHO’s activities on emergency contraception form part of its work to provide access to high-quality services for family planning, particularly for the most vulnerable populations. This work is shaped by the WHO
Global Reproductive Health Strategy.
In addition, through the UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and
Research Training in Human Reproduction (HRP), research is carried out that aims to provide the widest range of safe and effective family planning methods, as well as clinical research into novel methods or
uses.
WHO reaffirms its commitment to keeping emerging evidence under close review through its Continuous
Identification of Research Evidence (CIRE) system.
For more information contact:
WHO Media centre
Telephone: +41 22 791 2222
E-mail: mediainquiries@who.int
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(For use by provincial/regional, district/county/local authorities and officers in charge of health facilities.)
Objectives of Supervision and Monitoring Visits:
• To increase the knowledge and strengthen the skills of health providers to effectively manage
the logistics system for FP including EC .
• To identify performance weaknesses, and improve performance through on job training as
needed.
• To ensure that established logistics guidelines and procedures regarding FP/EC commodities
are being followed.
• To estimate the required quantities of FP commodities including EC per . that are ordered or
issued
• To assess whether clients are getting the services they want when they need them
• To verify that all records are correctly maintained and reports are submitted on time.
• To determine the quantity of supplies to order or issue
• To discuss the way forward with the local health management teams with a view to increasing
access to FP/ECPs in the community and clients seeking these services
1. Health Facility Characteristics
a) Name of facility and postal address…….…………………………………………
b) Type of Facility (Circle appropriate code: Hospital = 1; Health center = 2; Dispensary = 3;)
c) Managing authority (Circle appropriate code: Government=1; Faith-based = 2; NGO=3;
Private = 4; Other=5)
d) District/County/Local authority…….…………………………………………
e) Province/Region…….…………………………………………
f) Date of visit …….……………
g) Person interviewed …….……………………………………
2. Personnel Characteristics
Indicate the number of staff working at the facility who are trained in FP including EC

Cadre
Medical officers
Clinical officers
Nurses

Pharmacy staff

Others (specify)
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Total no. in
the facility

No. of staff working in the facility trained in FP including EC in the
past 1-3 years (in service)
No. trained in FP &
EC (in service)

No. trained in other RH services e.g., STIs/
HIV, gender issues, safe motherhood, etc.

3. FP/EC Staff Training
a) Are there regular continuing medical education /OJT programs in the district(s)/facilities on
FP/EC activities?
b) How do you ensure that as many staff as possible in the district(s)/facilities have access to
these updates?
4. Availability of FP/EC Tools in the Facility
Are the following tools available and in use in the facility?
Yes in use
Place tick √

Tools available

FP register with EC column

Not in use
Place tick √

Explanation if tool (s)
not in use

District monthly contraceptives request and
reporting form

Facility monthly contraceptives request and
reporting form
Job aids (F/EC)
Other (specify)

5. Are the Following Materials Present in the Health Care Provider’s Room?
Materials available

National FP Guidelines

Yes in use
Place tick √

Not in use
Place tick √

Explanation if tool(s) not in use

Post-rape/SGBV guidelines

FP job aids inclusive of EC ones
EC counseling job aid
Others (specify)

6. Status of Commodities During the Month
Did the facility experience stock outs of the following commodities for more than 7 days last
month? (Place a tick in the appropriate “yes” or “no” column for each of the items listed). If FP
commodities were not available, discuss with the facility staff and outline the reasons in the appropriate row in the table.
Commodity stock outs for more than 7 days
a)

Combined oral pill (COP)

c)

IUD

b)
d)
e)
f)

g)
h)
i)

Y

N

Reasons for stock outs (if response was “Y”)

Emergency contraceptive pills
Depo Provera

Implants (e.g., Jadelle, Implanon,
Sino-implant)
Male condoms

Female condoms
Microlut

Others (specify)
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7. ECP Provision to Clients
i)

Which cadres of health care providers prescribe ECPs to the clients?

ii)

In which areas of the facility can EC services be accessed by the clients?

iii) Are the EC services and commodities accessible at night and in the weekends?
iv) What EC regimes are used?
• Dedicated pill
• “Yuzpe” regimen
v) Find out from the district/health facility the most common indication (s) for ECPs in their
respective areas/region(s):
• Rape
• FP method failure
• Just had unprotected sex
• Others (specify_________________________)
8. Service Statistics
Check for the number of clients who received FP and EC services from the facility/district or
county in the last completed quarter.
9. Comments/remarks
a) Outline some of the achievements, program strengths and available opportunities for strengthening
integration activities for RTIs/STIs/HIV within reproductive health settings in the facility, etc.
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
b) Outline some of the key challenges, and constraints experienced during the month.
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
10. Supervision and Monitoring Team During this Visit Comprised the Following Officials:
a) Name ___________________ Designation _________________Dept/Division/Unit. __________
b) Name ___________________ Designation _________________Dept/Division/Unit. __________
c) Name ___________________ Designation _________________Dept/Division/Unit. __________
d) Name ___________________ Designation _________________Dept/Division/Unit. __________
e) Name ___________________ Designation _________________Dept/Division/Unit. __________
Supervision and Monitoring Report was prepared by:
Name ______________________ Designation _________________Dept/Division/Unit. __________
Source: Kenya Health Information System. 2010. MOH Monthly Supervision and Monitoring Tool (DRH MOH).
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H.7
Key M&E
Indicators
for FP
Commodities/
EC Pills
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This table lists the indicators for FP commodities/EC pills (adapted from Reproductive Health, Supplies Coalition, Monitoring and Evaluation Framework (2007–2015). The indicators are listed under
each objective, broad goal and strategic area.
Indicator

Method of collection/verification

Goal 1: Increase predictability and sustainability of financing for FP/EC supplies
Objective 1: Mobilize additional new resources
i) National budgetary line item for FP commodities
Government reports; MOH or MOF verification of budget
including EC pills
line item
ii) Increase in donor funding for FP commodities includ- Validated, procured, and paid for reproductive health suping EC pills in the past 1–3 years
plies from government records in the past 1–3 years
Objective 2. Access existing resources in support of FP/EC Supplies

• Proportion of the country’s health budget for FP com- Government reports; MOH or MOF verification of budget
modities including EC pills actually spent in the last 3 line item for RH supplies in the past 1–3 years
years
Objective 3. Mobilize total market resources for FP/EC supplies
a) Examples of initiatives in the country for expanding
Market segmentation studies; PPPs; reports from partners
the total market for FP commodities including EC pills such as PSI, among others
b) Increase in the non-public sector share of the market Market surveys undertaken by social marketing partners on
for condoms, pills including EC pills
sales and others
Goal 2. Strengthen the capacity of health systems to sustain FP/EC supplies
Objective 1. Strengthen existing systems
i) A functional FP commodity committee or similar
Program reports on existence and performance of commechanisms for managing RH/FP supplies in place
modity security committees or taskforces
ii) Levonorgestrel or equivalent products listed on the
Verify from the national essential drugs list
national essential drug list
iii) Monitor the supply chain for ECPs in the public sector MOH program eports and those from key partners assisting
at all levels periodically
governments with supply chain performance
Objective 2. To avert RH supply disruptions at national level
Minutes of the meetings/decisions taken and carried
• Availability and use of guidelines/ procedures for
averting EC stock shortage
through
Objective 3. Develop systems for emergency situations
a) Number of doses or units of dedicated ECPs issued to Database at central warehouses in the public sector.
clients or distributed* in the last one complete year in Records of main EC brand distributors. Additional records
both the public and private sector
could be obtained from other humanitarian agencies
Findings from studies undertaken; reports of
b) Initiatives to integrate provision of FP/EC Pills into
humanitarian relief efforts
humanitarian efforts in RH supplies delivery
Goal 3: Steer EC mainstreaming activities within the broader RH services
Objective 1. Foster greater harmonization among stakeholders at country level
• Examples of coordinated action by partners in a
Narratives of instances from working groups, partners and
country, with the aim of strengthening the security of country-led teams
FP commodities/EC pills
Objective 2. Promote new knowledge
i) Examples of all new tools, publications, and research Routine collection of reports and initiatives by MOH and
initiatives produced in the past 1–3 years on EC
from partners
mainstreaming work.
ii) Annual increase in visits to the country’s RH/FP (or
Website hit figures on FP commodities/EC pills and EC
equivalent) website
mainstreaming activities produced by Active Elements
(website host)
Objective 3. Establish support systems
a) Availability of an M&E report on performance of FP
Analysis and evaluation of results of indicator changes
services including EC activities against baseline
values in both public and private sectors
b) Identify sustainable ways of mainstreaming EC activi- Minutes of the meetings
ties into the broader RH activities
Routine collection of reports
Records of supplies at services such as SGBV centers
*In functional partnerships, it is feasible to obtain this information from records of the main EC brand distributors.
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